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Abstract 
Asymmetric Epoxidation of Enol Ethers and Esters Using Iminium Salt Catalysts 
Synthesis of α-Hydroxy-Carbonyls 
 
Iminium salt organocatalysts can provide high selectivity and high efficiency in catalytic 
asymmetric epoxidation. Enantiomerically-enriched epoxides are useful intermediates that 
have found many applications in asymmetric synthesis, and development of efficient 
catalysts for asymmetric epoxidation has received considerable attention. In this manuscript, 
we describe the preparation, and use of highly selective iminium salt organocatalysts for 
asymmetric epoxidation. The new catalysts have been tested in the catalytic asymmetric 
oxidation of enols, and provide up to 98% ee. Also we tried to synthesize tatarinoid B 74 
which used for the treatment of central nervous system diseases in traditional Chinese 
medicine. 
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1.1  Introduction:  Chirality 
 
A chiral molecule is a molecule that is not superimposable on its mirror image; and, mirror 
images of a chiral molecule are enantiomers with respect to each other. For example, our 
hands are chiral (Figure 1.1).1  
 
 
Figure 1.1: Our hands are chiral 
 
Most chiral molecules encountered in synthetic organic chemistry are chiral due to the 
presence of a stereogenic centre, in most cases, a carbon atom attached to four different 
substituents, and the absence of a plane of symmetry. Examples of chiral molecules include 
amino acids, containing a carbon centre bound to a proton, a carboxylic acid moiety, an 
amino group and another substituent (often represented as a R group) which differs from 
amino acid to amino acid (except glycine, where the substituent is a proton). For example, 
alanine’s R group is a methyl group (Figure 1.2).1  
 
NH2
R
O
OH
NH2
R
HO
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R
 = Me
 
Figure 1.2: (S) - and (R)-alanine 
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1.1.2 Chirality in our life  
 
In 1957, a drug called thalidomide was launched to help women who suffer from morning 
sickness during pregnancy.2 The drug was distributed and used in many places. After a short 
time, thalidomide side-effects appeared. Miscarriages increased and many babies were born 
with malformed limbs.2 When investigating the causes for the increase, researchers 
identified one thalidomide enantiomer as the source of the problem. Indeed, thalidomide was 
sold as a racemic mixture and (S)-thalidomide causes birth defects while (R)-thalidomide 
cures morning sickness (Figure 1.3).3 The adverse consequences observed show us the 
importance of chirality. Stereoselective synthesis is the key to producing new drugs as single 
enantiomers. 
 
N
O
O
NH
O
O N
O
O
NH
O
O
(R)
-thalidomide (S)
-thalidomide  
Figure 1.3: Thalidomide enantiomers. 
 
 
1.2 Asymmetric synthesis 
 
Asymmetric synthesis, also called chiral synthesis or enantioselective synthesis is a chemical 
reaction which produces unequal amount of one isomer of the product due to the influence 
of chirality present in the reagent(s) and/or catalysts.4 (Scheme 1).5 
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Scheme 1: Non-selective and asymmetric reductions. 
 
1.3 Chiral auxiliaries  
 
A chiral auxiliary is an enantiomerically pure group that is temporarily attached onto a 
substrate in order to control the stereochemical outcome of a reaction.6 For example, the 
reaction between cyclopentadiene 3 and benzyl acrylate 2, both achiral reagents, leads to the 
formation of the product as a single diastereoisomer (the endo product) and as a racemic 
mixture (Scheme 2).4  
 
Cl
O
OBn
O
BnOH
O O
Bn
1 2 3
O OBn
Scheme 2: Non-selective Diels Alder reaction 
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However, when a chiral auxiliary formed from natural amino acid (S)-valine is attached    to 
the dienophile, the product is obtained as a single diastereoisomer and a single enantiomer 
4. The chiral auxiliary is removed following hydrolysis to give product 5 in 93% ee (Scheme 
3).4  
 
Cl
O OHN O
O
Base N
O
OO
N
O
O
O O
Bn
5
4
H2N
OH
H EtO
O
OEt
K2CO3
110°C
 
Scheme 3: Chiral auxiliary-controlled Diels Alder reaction 
 
 
 
1.4 Asymmetric catalysis 
 
Asymmetric catalysis promotes the formation of one product stereoisomer over the possible 
other(s) through a catalytic mechanism.7 The mechanisms of generating the new chiral 
Chapter 1 - Introduction 
 
 
6 
 
center(s) can be complicated and are not well understood in many systems.8 Alkenes and 
carbonyl-containing compounds are widely used as prochiral starting materials. Epoxidation 
reactions are one of the most effective asymmetric transformations  to convert a prochiral 
compound into a chiral product.4 The asymmetric epoxidation of olefins is an effective way 
to synthesize enantiomerically pure epoxides.5 
 
 
1.5  Epoxides 
 
An epoxide or oxirane is a three-membered ring which has an oxygen atom attached to two 
carbon atoms (Figure 1.4). Currently, epoxides are one of the most important synthetic tools 
used to prepare many natural products.9 
 
R3
R4R2
R1 O
 
Figure 1.4: The epoxide moiety 
 
The angle between the atoms in the ring is about 60° (versus a 109° angle for a tetrahedral 
carbon centre) which means the ring strain is high. Because of high strain and the 
electronegative oxygen which increases the δ+ character of the carbon atoms, epoxides can 
be attacked by nucleophiles.10 Indeed, the carbon centres can be attacked under basic or 
acidic conditions when a nucleophile is added (Scheme 4). 
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R1 R3
HR2
O
R1 R3
HR2
O
H
Nu
H
Acid
 conditions
R1 R3
HR2
O
Nu
Nu
R3
H
R1
R2
O
Nu
R3
H
R1
R2
HO
Base
 conditions
Nu
R1
R2 OH
R3
H
A H
 
Scheme 4: Nucleophilic addition to an epoxide 
 
Under acidic conditions, the nucleophilic attack occurs at the most substituted carbon centre, 
due to the higher stability of the developing partial cation. In contrast, under basic conditions, 
the least substituted carbon is attacked. 
 
 
1.5.1 Epoxides in natural products 
 
The epoxide functional group can be found in many natural products. Moreover, many drug 
molecules are derived from natural products. There is pressure on pharmaceutical companies 
to provide more potent pharmaceuticals to use in the treatment or curing of illnesses. For 
instance, Ixempra 6 is used as an anti-cancer drug.  Ixempra is a semi-synthetic analog of the 
bacterial natural product epothilone B 7 (Figure 1.5).11     
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N
S
NH
OH OO
HO
O
N
S
O
OH OO
HO
O
6 7  
Figure 1.5: Advanced breast cancer drug Ixempra 6 and epothilone B 7. 
 
 
1.6 Epoxidation Reactions 
 
1.6.1 Prilezhaev Reaction 
 
In 1909, Prilezhaev reported the use of peroxycarboxylic acids 8 for the first non-selective 
epoxidation reaction.12 The mechanism of this alkene epoxidation begins with alkene double 
bond nucleophilic attack on the peroxyacid electrophilic oxygen atom (Scheme 5).13 The 
reaction is sterospecific as both C-O bonds are formed concurrently. A theoretical study by 
Houk supported a spiro transition state.14  
 
 
R
O
O
O
H
R4
R1
R2
R3
R4R2
OR1 R3
R
O
OH
8
R1
R4R2
R3
O
O R
OH
 
Scheme 5: Use of peroxycarboxylic acids. 
 
1.6.2 Sharpless Asymmetric Epoxidation 
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Sharpless was the first to enter the field of asymmetric epoxidation using metal catalysts. 
Sharpless used titanium tetraisopropoxide, Ti(Oi-Pr)4. He believed that the presence of a 
chiral ligand with the titanium catalyst would lead to asymmetric induction. The best ligand 
is diethyl tartrate (Scheme 7).18 
 
 
CH2OH CH2OHO
(enantioselective)
a,
 
Scheme 7: a) Ti(Oi Pr)4, (+) or (–) DET, tBuOOH, DCM, –20 °C. 
 
 
In 1981, when this reaction was first reported, it was the first highly enantioselective 
epoxidation reaction. For this work, he was awarded a Nobel Prize in 2001.19 The Sharpless 
system reacts with substrates which have an allylic alcohol moiety. Excellent enantiomeric 
excesses of up to 95% ee for epoxide products and high yields were achieved using his 
methodology. Hydroperoxide reagents are used as the stoichiometric oxidant, usually t-butyl 
hydroperoxide. The oxidizing agent, the catalyst titanium tetraisopropoxide Ti(Oi-Pr)4, with 
diethyltartrate ligand (DET) are a very important mixture to furnish high enantioselectivity.20 
Sharpless tested many different allylic alcohol substrates types and most gave 
enantioselectivities higher than 90% (Table 1).21 
 
 
 
Table 1. Asymmetric epoxidation of various allylic alcohols. 
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Substrate Epoxide Product ee (%) 
Ph
Ph
OH
 
Ph
Ph
OHO
 
95 
OH
 
OHO
H
 
95 
OH  
OH
H
O
 
94 
 
 
Much work has been carried out to elucidate the reaction mechanism: first, an active complex 
involving two titanium atoms and two tartrate ligands 9 is formed. The oxidizing agent (t-
BuOOH) displaces an isopropoxide ligand and one of the tartrate carbonyl groups when it is 
added to complex 10. Next, the allylic alcohol reacts with the complex and displaces the last 
isopropoxide ligand from the reactive titanium center of complex 11. In this case, the reactive 
oxygen atom of the hydroperoxide is delivered to the lower face of the alkene because of the 
shape of complex to give epoxide 12 in high enantiomeric excess (Scheme 8).22 
 
 
Chapter 1 - Introduction 
 
 
11 
 
Ti
O
O
O
EtO
O
Ti
O
O
O OEt
EtO2C
9
TI(Oi
-Pr)4
L-(+)
-DET
i-Pr
Oi-Pr O
i-Pr
i-Pr
O
CO2Et Ti
O
O
O
EtO
O
Ti
O
O
O
EtO2C
i-Pr
Oi-Pr
O
i-Pr
O
CO2Et
EtO2C
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t-BuOOH
Ti
O
O
O
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O
Ti
O
O
O
EtO2C
i-Pr
Oi-Pr
O
O
CO2Et
EtO2C
t-Bu
R
O
Ti
O
O
O
EtO2C
O
O
EtO2C
t-Bu
R
HO
R
O
10
11
12
HO
R
 
Scheme 8: Sharpless epoxidation mechanism 
 
The oxygen atom is added onto the top or bottom face of the alkene depending on the 
configuration of the tartrate ligand: when the natural L-(+) tartrate is used, the oxygen is 
added onto the bottom face and the peroxide attacks the top face when unnatural D-(–)-
tartrate is used (Scheme 9).23 
R3
R1
R2
OH
EtO2C
OH
CO2Et
OH
EtO2C
OH
CO2Et
OH
R3
R1
R2
OH
O
R3
R1
R2
OH
O
 
Scheme 9: Selectivity mnemonic for the Sharpless epoxidation    
16.3     Jacobsen-Katsuki Epoxidation 
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In 1990, another example of a transition metal-mediated epoxidation was discovered. The 
Jacobsen-Katsuki epoxidation was the first epoxidation reaction involving metal to convert 
alkenes into the corresponding epoxides.24 This reaction involves a manganese-salen based 
catalyst (Figure 1.6).24 The metal catalyst does not require the presence of an allylic hydroxyl 
group in the substrate to obtain high enantioselectivities unlike Sharpless’s epoxidation. 
 
Mn
Cl OO
NN
Mn
OO
NN
Ph Ph
OAc
1413  
Figure 1.6. Examples of Katsuki’s 13 and Jacobsen’s 14 manganese-salen catalysts. 
 
 
A range of oxidants can be used to oxidize the manganese (III) metal centre to manganese 
(V) such as Oxone, sodium hypochlorite and hydrogen peroxide.24  A range of alkyl and aryl 
substituted olefins were oxidized by Jacobsen’s manganese-salen catalysts in good to high 
enantioselectivities (Table 2).25 
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IO
R2
R3
R1 O
* *R3
I
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Alkene 
 
Catalyst 
 
Yield% 
 
ee% 
 
Configuration 
 
 
Ph
Ph
 
 
 
 
15 
 
 
63 
 
 
33 
 
 
(-)S,S 
 
 
 
 
 
16 
 
 
72 
 
 
78 
 
 
(+)1R,2S 
 
 
 
 
 
16 
 
 
50 
 
 
59 
 
 
(-)1R,2S 
 
 
                        Table 2. The first examples of using a manganese-salen catalyst. 
 
 
Subsequently, Jacobsen tried different olefins with catalyst 14 and gave high 
enantioselectivities above 90% (Table 3).25   
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Olefin 
 
ee% 
 
 
Yield% 
 
 
O
NC  
 
 
 
97 
 
 
96 
 
Ph
 
 
 
92 
 
84 
 
Table 3. Asymmetric epoxidation of olefins using catalyst 14. 
 
1.7 Asymmetric Epoxidation of Silyl Enol Ethers and Enol Esters 
 
1.7.1 Rubottom Reaction 
 
In 1974, Rubottom reported the transformation of a ketone into an α-hydroxycarbonyl by 
means of epoxidation of the corresponding trimethylsilyl enol ether with m-
chloroperbenzoic acid (m-CpBA) under basic or acidic conditions.17 The epoxidation of the 
silyl enol ether first leads to a silyloxy carbocation, a 1,4-silyl migration gives the α-silyloxy 
ketone, and finally the silyl group is removed to afford the α-hydroxycarbonyl (Scheme 6).5 
 
R1
O SiR3 m-CPBA
R1
O SiR3
R2
O
R1
O SiR3
R2
OH
H
1,4-Silyl
 migration
R2
R1
O
R2
O
R1
O
R2
OHSiR3 H2O
 
Scheme 6: Rubottom oxidation. 
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1.7.2 Shi Asymmetric Epoxidation  
 
Shi prepared chiral hydroxyl ketones using asymmetric epoxidation of enol ethers and enol 
esters. Fructose derived ketone 17 was used as catalyst and Oxone as oxidant. Shi found that 
enol esters and enol ethers are effective substrates, giving hydroxy ketones 21 or oxy-
substituted epoxides 19 in high enantioselectivities. 
 
 
Table 4. Asymmetric Epoxidation of Silyl Enol Ethers and Esters by Ketone 17 
R1
R2
OR
O
OO
O
OO
Oxone
R1
R2
OR
O
R1
R2
O
OSiR3
or R1
R2
O
OH
18 19
17
20 21
R
 = R
'
CO
R
 = SiR
'
3
 
 All reactions were carried out at 0 °C (bath temperature) with substrate (1 equiv.), ketone (0.3 equiv.), 
Oxone (1.38 equiv.) and K2CO3 (5.8 equiv.) in organic solvent (15 mL) 
 
Substrate Product t (h) Yield (%) ee (%) 
 
Ph
OTBS
 
Ph
O
OH  
 
2 
 
80 
 
90 
OTMS
 
O
OH
 
 
1 
 
70 
 
83 
OAc
 
OAc
O
 
 
2 
 
59 
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Ph
OAc
 Ph
OAc
O
 
 
2 
 
66 
 
91 
 
1.7 Organocatalysis 
 
Organocatalysts are organic molecules, typically formed from hydrogen, carbon, nitrogen, 
phosphorus and sulfur atoms.26  There are many advantages to the use of organocatalysts,  
including the fact that many organocatalysts are prepared from cheap, simple and low- 
weighting starting materials, do not contain metals, and are usually not toxic. The first 
reported asymmetric organocatalytic reaction was published by Fiske and Bredig. They 
observed that the addition of hydrogen cyanide to benzaldehyde 22 was catalyzed by 
quinine, and that the resulting cyanohydrin 23 was optically active (Scheme 10).27 
 
HCN
O
N
N
HO
OHNC
Cyanohydrins
 
up
 
to
 
10%
 ee
22 23
 
Scheme 10: Fiske and Bredig asymmetric organocatalytic reaction 
 
In 1974, Hajos and Parrish reported one of the earliest enantioselective reactions used in 
synthetic organic chemistry. L-proline was used as a catalyst to produce the Wieland-
Miescher ketone (Scheme 11).28 
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O
O
O
N
H
CO2H
O
O
24  
Scheme 11. The Wieland-Miescher ketone. 
 
 
1.8.1 Oxaziridine - Mediated Epoxidations 
 
The first chiral oxaziridine 25 was reported by Davis in 1982. Davis used Oxone or m-CpBA 
to oxidize a sulfonylimine or sulfamylimine formed from the reaction between the diethyl 
acetal of an aromatic aldehyde and bromocamphor sulfonamide. For the epoxidation of 1-
phenylcyclohexene, the highest enantiomeric excess was 41% (Scheme 12).29 
 
Ph
NO2
Cl
N
HS
O
O
O
Br
H
O
25 PhO
 
Scheme 12: Davis’s oxaziridine 25. 
 
Davis tried to improve the enantioselectivity by a using new chiral oxaziridine 26. The 
asymmetric epoxidation of methylstyrene produced the corresponding epoxide in 61% 
enantiomeric excess (Scheme 13).30 
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Scheme 13: Davis’s oxaziridine 26. 
 
 
1.8.2 Lusinchi and Bohé’s Initial Studies 
 
Oxaziridinium salts were reported by Lusinchi in 1976. Oxaziridinium salts have the ability 
to transfer the oxygen to nucleophilic substrates such as alkenes, amines, sulfides and imines. 
Lusinchi prepared the first oxaziridinium salts (Scheme 14) starting from imine 27. 
Methylation of imine 27 affords the corresponding iminium salt 28 followed by oxidation to 
furnish oxaziridinium salt 29.31 
 
 
N
FSO3Me
N
ArCO3H
N
O
27 28 29  
Scheme 14: Synthesis of the first oxaziridinium salt. 
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Later, they reported the synthesis of dihydroisoquinolinium-derived oxaziridinium salt 30 
which was then applied to the epoxidation of alkenes (Table 5).32 
 
 
Table 5. Lusinchi’s epoxidation using oxaziridinium salt 30 
 
N
O
BF4
30
CH2Cl2
2h,
 rt N
BF4 O
 
 
 
 
 
 
 
 
 
In 1993, the first chiral oxaziridinium salt 31 was prepared by Lusinchi and Bohé in five 
steps starting from (1R,2R)-(+)-norephedrine (Scheme 15).33 
Substrate Yield (%) 
 
84 
 
75 
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O H
H2N
Ph
OH NaBH4
NH
PhHO
NH
Ph
CF3CO2H
H2SO4
N
Ph
NaOCI
NaOMe
Me3OBF4
MeOHN
Ph BF4
mCpBA
MeOH
31
N
Ph
O
Me3OBF4
MeOHN
Ph BF4
O
mCpBA
MeOH
 
Scheme 15. Synthesis of chiral oxaziridinium salt 31. 
 
Bohé subsequently showed that analogues of dihydroisoquinolinium 32 containing protons 
on the carbon α to the nitrogen lose their activity through dehydration to form the 
corresponding isoquinolinium salt 33 (Scheme 16) .34 
 
N
O
H
BF4
32
N
BF4OH
N
BF4
33
 
 Scheme 16. Base-catalysed oxaziridinium decomposition.  
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Bohé prepared achiral 3,3-disubstituted-dihydroisoquinolinium catalyst 34 to mediate the 
epoxidation of alkenes. He prevented irreversible isomerisation from happening by replacing 
all the protons on the carbon α to the nitrogen with methyl groups (Figure 1.7) .35 
 
N
BF4
34  
Figure 1.7 Bohé’s improved 3,3-disubstituted-dihydroisoquinolinium catalyst 34. 
 
 
 
1.8.3 Aggarwal’s Chiral Binaphthalene Azepinium Salt Catalyst 
 
In 1996, the chiral binaphthyl-based iminium salt 35 was prepared by Aggarwal. 
Epoxidation of 1-phenylcyclohexene gave the corresponding product in 71% ee (Figure 1.8) 
using Oxone as the oxidant and NaHCO3 in a mixture of acetonitrile/water.35 
 
 
O
31%
 ee
O
O
45%
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 ee
N
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35
(R,
 
R)(R,
 
R)(R
, R)
 
Figure 1.8 
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1.8.4  Armstrong’s Catalysts  
 
The first a range of exocyclic iminium triflate salts formed and used as epoxidation catalysts 
were made by Armstrong. These catalysts were prepared by condensation of N-trimethylsilyl 
pyrrolidine with aromatic aldehydes. Some catalysts gave high yields, for example, the 
catalyst ortho-trifluoromethyl group 38 reached up to 94% yield for the epoxidation of 
various alkenes (Scheme 17).37, 38 
 
 
N
SiMe3
N
X
OTf
ArCHO
TMSOTf, Et2O
36 X
 = H
37
 
X
 = p-Cl
38
 
X
 = o-CF3
 
Scheme 17. Armstrong’s Catalysts. 
 
 
Later, he tested the effectiveness of chiral iminium salt 39 using oxone to oxidize 1- 
phenylcyclohexene, giving the corresponding epoxide in 22% ee (Figure 1.9).38 
 
 
ClN
CIO4
39  
Figure 1.9 
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1.8.5  Yang’s Chiral Iminium Salts 
 
Yang reported chiral iminium salts which were made from the condensation of amines with 
aldehydes in-situ under acidic conditions. For example, the epoxidation of trans-stilbene 
gave 65% enantiomeric excess by using 3,3-dimethylbutanal (aldehyde) 41 and (2S,5S)-5-
(cyclohexanecarbonyl)-N-cyclohexyl-pyrrolidine-2-carboxamide (amine) 42 in presence of 
Oxone and NaHCO3 (Figure 1.10) .39 
 
 
N
H
O
HNOO
H
4241  
Figure 1.10 
 
 
 
1.8.6 Page’s Studies 
 
In 1998, Page designed new iminium salts for organocatalytic asymmetric epoxidation. Page 
tried to increase the enantioselectivity by bringing the chiral centre closer to the site of the 
reaction.39 In his procedure he used dihydroisoquinolinium iminium salts 43 - 45 (5-10 
mol%) and Oxone as the oxidant for asymmetric epoxidation of olefins, reaching 73% 
enantiomeric excess (Table 6). 40 
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Table 6. Screening of dihydroisoquinolinium salts for the epoxidation of olefins. 
 
O
Br
O
i)
 
Br2
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reflux,
 
1
 
h
ii)HBr
 
reflux
R
*
NH2
NaBPH4
EtOH
2h
HN
NH2Ph
NH2
NH2
HO
43
 
R*= 44
 
R*= 45
 
R*=
47%
 
yield39%
 
yield 68%
 
yield
N+
R*
-
BPh4
N+
R*
-
BPh4
R
''R
R
'
R
''R
R
'
O
Oxone,
 
Na2CO3
CH3CN:H2O
, 0
 °C  
 
 
Alkene 
 
Catalyst 
 
ee (%) 
 
Yield (%) 
major 
enantiomer 
 
45 73 78 
 
(+)-(R,R) 
 
45 40 68 
 
(+)-(R,R) 
 
43 25 39 
 
(-)-(S,S) 
 
43 14 47 
 
(-)-(S,S) 
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Catalyst 45 gave the highest enantiomeric excess for the epoxidation of 1-
phenylcyclohexene and gave 73% ee for the epoxidation of trans-stilbene. There are many 
advantages to Page’s iminium salt catalysts; they are easy and rapid to prepare because they 
do not require column chromatography for purification at any stage and some of the starting 
materials are commercially available or easy to make. Page’s iminium salt catalysts can be 
used for the epoxidation of many different olefins. Page used tetraphenylborate as a counter 
ion to obtain crystalline iminium salts instead of the bromide counter ion, which often gave 
an oily product to make purification easier.39 Page suggested a catalytic cycle to understand 
how the oxygen transfer from the oxaziridinium salt to the olefin occurs (Scheme 18).41 
 
N
R*
O
N
R*
O
N
R*
N
R*O
N
SO4
-2 SO4
-2
R2
R3
R1
R2
R3
R2
R3
R1 O
R2
R3
R1 OR
*
R1
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O3SOO3SO
O
X
 
Scheme 18. Page’s suggested catalytic cycle for oxaziridinium-mediated asymmetric epoxidation. 
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The first step of Page’s proposed mechanism involves an attack from the nucleophilic 
persulfate anion onto the carbon of the iminium bond. Two diastereoisomers can be formed 
from the persulfate attack because the nucleophilic species can attack the si or re face of the 
iminium species.41 Two diastereoisomeric oxaziridinium species can be formed by 
irreversible expulsion of sulfate. Page believed this step was the rate determining step under 
the reaction conditions.41 Each diastereoisomeric oxaziridinium species can transfer the 
oxygen atom to one prochiral face of the substrate with a different degree of enantiomeric 
excess.41 
 
1.8.6.1 Page’s catalysts conditions 
 
Many different factors can influence the selectivity of the epoxidation reaction; for example, 
the effect of the temperature, the effect of the solvent system, the effect of the counter ion 
and catalyst loading were studied to improve the selectivity.41 
 
1.8.6.2 Effect of the solvent 
 
Page tested different solvents as mixtures with water in a 1:1 ratio using catalyst 45 and 
tetraphenylborate and perchlorate anions as the counter ions for the epoxidation of 1-
phenylcyclohexene. Page started with formamide as the solvent: after 3 h, no reaction was 
observed using the perchlorate or the tetraphenylborate salts. The reaction gave 26% ee with 
100% conversion using trifluoroethanol. When dichloromethane was used, 50% conversion 
was observed, maybe due to Oxone’s low solubility providing lower reactivity. Acetonitrile 
gave the best result. For example when catalyst 45 was used with tetraphenylborate as the 
counter ion for epoxidation of 1-phenylcyclohexene in a mixture of acetonitrile and water 
(1:1) at low catalyst loading (0.5 mol%) gave 40% ee after 1 h.41 
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Table 7. Effect of co-solvents on epoxidation of 1-phenylcyclohexene. 
 
O
Catalyst
 
45
Oxone
 
(2
 equiv)
Na2CO3
 
(4
 equiv)  
 
 
 
Organic 
Solvent 
 
Counter Ion 
 
Conv. (%) 
 
ee (%) 
 
Configuration 
CF3CH2OH - CIO4 100 26 (-)-(R,R) 
CF3CH2OH - BPh4 100 26 (-)-(R,R) 
CH2Cl2 - CIO4 50 33 (-)-(R,R) 
CH2Cl2 - BPh4 0 -  
MeCN - CIO4 100 20 (-)-(R,R) 
MeCN - BPh4 100 40 (-)-(R,R) 
H2NCHO - CIO4 0 -  
H2NCHO - BPh4 0 -  
 
 
1.8.6.3 Effect of temperature  
 
Page studied the effect of temperature on his methodology for the epoxidation of olefins. 
Limitations were quickly discovered: at −10 °C, a 1:1 mixture of acetonitrile/water solvent 
system freezes, and, at room temperature, decomposition of Oxone occurs.41 
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1.8.6.4 Effect of Counter-Ion 
 
Page used catalyst 45 for the epoxidation of 1-phenylcyclohexene with different counter-
ions: the tetrafluoroborate, hexafluorophosphate, perchlorate, periodate and the 
tetrafluoroborate anions were evaluated under the same reaction conditions: sodium 
carbonate as the base, Oxone as the stoichiometric oxidant and the best solvent system  
acetonitrile/water (1:1) at 0 °C. The highest enantioselectivities were produced by using the 
tetraphenylborate (40%) and the periodate salts (35%) (Table 8). The perchlorate salt gave 
20% ee, which was the lowest enantioselectivity.41 
 
Table 8. Effect of counter-ion on epoxidation of 1-phenylcyclohexene. 
 
Catalyst
 
45
Oxone
 
(2
 equiv)
Na2CO3
 
(4
 equiv)
MeCN/H2O
 
1:1
O
 
 
 
Counter-Ion 
 
ee (%) 
 
Conv. (%) 
 
Configuration 
-CIO4 20 100 (-)-(R,R) 
-IO4 35 100 (-)-(R,R) 
-PF6 28 100 (-)-(R,R) 
-BF4 28 100 (-)-(R,R) 
-BPh4 40 100 (-)-(R,R) 
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1.8.6.5 Effect of catalyst loading  
 
To improve the enantioselectivity, Page tried to increase the catalyst loading from 0.1 to 0.5 
and found the enantioselectivity increased with increased catalyst loading.41 
 
 
Figure 1.11. Effect of catalyst loading on the asymmetric epoxidation using iminium salt 45. 
 
1.8.6.6 Page’s Catalysts From Chiral 1,2-Amino Alcohol Precursors 
Containing a Primary Hydroxyl Group. 
 
Page prepared catalysts 46-49 (Figure 1.12) by condensation reactions between 2-(2-
bromoethyl) benzaldehyde and 1,2-amino alcohols. When these catalysts were employed in 
the epoxidation of 1-phenylcyclohexene, a racemic mixture of 1-phenylcyclohexene oxide 
was obtained. For the reactions with catalysts 46-48, 2 mol% of catalyst were used to 
complete the reaction, but with catalyst 49 the reaction gave full conversion in one hour 
using 0.5 mol% of the catalyst.43 
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46 47 48 49  
Figure 1.12. Page’s Catalysts Containing a Primary Hydroxyl Group. 
 
 
1.8.6.7 Page’s Catalysts From Chiral 1,2-Amino Alcohol Precursors 
Containing A Secondary Hydroxyl Group 
 
The catalysts 50 – 52 (Figure 1.13) contain a secondary hydroxyl group furnished from chiral 
1.2-amino alcohols. These catalysts gave better enantioselectivities (up to 33% ee) for the 
epoxidation of 1-phenyl-3,4-dihydronaphthalene using iminium salt 50 than the catalysts 
containing a primary hydroxyl group.43 
 
N
HO Ph
Br
N
HO
Ph
Ph
BPh4
N
BPh4
HO
H
50 51 52  
Figure 1.13. Page’s Catalysts Containing a Secondary Hydroxyl Group. 
 
1.8.6.8 Page’s Catalysts From Amino Ether Precursors 
 
Page reported catalysts 53 – 55 (Figure 1.14) prepared from amino ethers. Catalyst 55 
afforded poor enantioselectivity for the epoxidation of 1-phenylcyclohexene, up to 7% ee 
higher than catalyst 56. Catalysts 53 and 54 gave lower enantioselectivity than 55.43 
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N
N
MeO
-
BPh4
N
N
BnO
-
BPh4
N
-
BPh4
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53 54 55  
Figure 1.14. Page’s Catalysts Containing Amino Ether Group. 
 
 
1.8.6.9   Page’s Catalysts From Amino Acetal Precursors 
 
Page reported and tested catalyst 56, an acetonide-derived dihydroisoquinolinium 
tetraphenylborate salt, for the epoxidation of triphenylethylene, and observed similar 
enantioselectivities to catalyst 45 (up to 59% ee, Figure 1.14).43 Encouraged by the success 
of catalyst 56, Page prepared biphenyl iminium salt catalyst 57 and binaphthyl iminium salt 
catalyst 58. Biphenyl iminium salt catalyst 57 afforded 60% ee for the epoxidation of 1-
phenylcyclohexene with full conversion (Scheme 19).44,45 
O
O
N
BPh4
56
O
BPh4
N
O
O
N
O
O
BPh4
57 58  
Scheme 19. Reagents and conditions: iminium-salt 56-58 (5 mol%), Oxone (2 equiv.), Na2CO3 (4 
equiv.), CH3CN-H2O (1:1), 0 °C. 
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1.8.6.10   Tetraphenylphosphonium Monoperoxysulfate 
 
Page attempted to find alternative stoichiometric oxidants to Oxone, which requires the 
presence of water due to its poor solubility in common organic solvents. He looked for an 
oxidant that could be dissolved in organic solvent. That means the reaction could be 
conducted under non-aqueous conditions, and, crucially, the reaction temperature could be 
lowered below 0°C. The best stoichiometric oxidant to replace Oxone was 
tetraphenylphosphonium monoperoxysulfate (TPPP), which had been reported by Di 
Furia.44 Indeed, tetraphenylphosphonium monoperoxysulfate is soluble in many organic 
solvents. For example, the epoxidation of dihydronaphthalene using Oxone as the oxidant 
and catalyst 59 afforded dihydronaphthalene oxide in 45% ee, but when 
tetraphenylphosphonium monoperoxysulfate with catalyst 59 in CHCl3 at -40 °C, was used 
instead of Oxone, the product was obtained in 82% enantiomeric excesses (Scheme 20).47 
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Scheme 20. Page’s catalyst 59 shows increased enantioselectivities when changing from aqueous 
to non-aqueous conditions. 
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1.9 Conclusion 
This introduction has covered the importance of enantioselective synthesis and the field of 
asymmetric epoxidation in particular. Some asymmetric epoxidation reactions have been 
discussed including non-metal based and metal-based catalysis. This chapter also discussed 
the preparation and the use of oxaziridinium salts as oxygen transfer reagents. Finally, Page’s 
study in asymmetric catalytic oxygen transfer reactions was highlighted. 
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2.0 Results and Discussions 
 
Page started his work in 1998 on designing catalysts for asymmetric epoxidation by 
producing a number of iminium-based catalysts from chiral primary amines and an achiral 
bromoaldehyde (Scheme 2.1).1 
 
The idea behind the first design new cyclic chiral iminium salts based on a 
dihydroisoquinolinium moiety is to place the chiral centre in the exocyclic group close to 
the iminium nitrogen atom. Page thought this may lead to an increase in the enantiomeric 
excess by bringing the asymmetric centre closer to the site of oxygen transfer.2,3 Examples 
of this include binaphthyl azepinium salts 9 and 10, dihydroisoquinolinium salts 2, 4, 5 and 
6, and biphenyl azepinium salts 7 and 8.4  
 
O
O
Br
Br2
, CCl4
1
 
h O
Br
N+
R
-
BPh4HBr
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 min
RNH2
, EtOH
NaBPh4
2
 
h
 
Scheme 2.1 - Page’s concise route towards dihydroisoquinolinium-based catalysts 
 
Early work using fenchylamine-derived catalyst 1 gave 73% ee for the epoxidation of 
stilbene. Page also prepared acetal containing iminium catalyst 2, which performed better 
than fenchylamine catalyst 1, leading to higher enantioselectivity. For example, epoxidation 
of triphenylethylene 3 with catalysts 1 and 2 gave 5% and 59% ee, respectively (Scheme 
2.2).5, 6  
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Scheme 2.2 - Iminium-based catalysts tested for epoxidation of triphenylethylene 3. 
 
In 2005, new catalysts were designed based on catalyst 2, adding substituents to the 4 
position on the phenyl ring: a sulfone group 4, nitro group 5 and methoxy group 6. Catalyst 
4 provided higher enantiomeric excess than 4-methoxy-substituted salt 6 and 4-nitro 
substituted salt 5 (Figure 2.1).7, 8 
 
O
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BPh4
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Figure 2.1 – Several dihydroisoquinolinium-based catalysts improved by Page. 
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The dihydroisoquinolinium moiety was replaced by a biphenyl backbone fused with a seven-
membered azepinium salt to yield a new generation of iminium salts, such as 7 and 8 (Figure 
2.2).5 
N
O
O
BPh4
N
O
O
BPh4
S
O
O
7 8  
Figure 2.2 – The most reactive biphenyl-derived catalysts from Page. 
 
In general, asymmetric epoxidation of 1-phenylcyclohexene with the biphenyl-derived 
catalysts induced higher ees than the six-membered ring dihydroisoquinolinium catalysts. 
Biphenyl catalyst 7 produced 1-phenylcyclohexene oxide in 60% ee compared to 41% ee for 
the six-membered ring catalyst 2. 
 
 
Moreover, the biphenyl-derived catalysts provide faster reactions: indeed, complete the 
consumption of the alkene substrate is observed after five to ten minutes whereas 
dihydroisoquinolinium catalysts need one hour under the same conditions (Table 2.1).9 
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Table 2.1 – Catalytic asymmetric epoxidation of alkenes using dihydroisoquinolinium and 
azepinium salts. 
 
R3
R2
R1 R3
R2
R1
O
Catalyst
 
(10
 mol%)
Oxone
 
(2
 equiv)
Na2CO3
 
(4
 equiv)
MeCN/H2O
 
(1:1)
, 0
 °C  
Alkene 
Ph
 
Ph
Ph  
Ph
PhPh  
Catalyst ee (%) 
Conv. 
(%) 
ee (%) 
Conv. 
(%) 
ee (%) 
Conv. 
(%) 
7 60 100 37 95 59 90 
2 41 55 52 52 59 54 
8 47 56 21 100 10 55 
4 39 100 32 100 50 100 
 
Subsequently Page reported binaphthyl-derived catalysts 9 and 10 which were used to 
oxidize 1-phenylcyclohexene in 91% ee under aqueous conditions (Figure 2.3).10 
 
BPh4
N
O
O
S
O
O9 10
N
O
O
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Figure 2.3 – Page’s binaphthyl azepinium catalysts 
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The aim of this project is to prepare a number of enantiomerically enriched α-hydroxy 
carbonyls by epoxidation of enol ethers and esters (Scheme 2.3). 
 
R
O
R
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R R
R
R
O
R
O
R
R
O
R
OH
 
Scheme 2.3 
 
 
The epoxidation process involves iminium salt catalysts 7, 4 and 9 and 
tetraphenylphosphonium monoperoxysulfate 11 as the oxidant under non-aqueous 
conditions (Figure 2.4).  
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Figure 2.4 – iminium salt catalysts and TPPP. 
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We have synthesised 12 enol ethers and esters from different substrates (Figure 2.5). We 
have chosen Silyl enol ethers 16 12, 18 23, acetate enol esters 1311, 15 32, 19 24, 2127, 23 31, 
phosphate enol ether 14 28, Trifluoroacetate enol ester 12 26 and enol benzoate 20 30. All 
enol ethers and esters have good enantiomeric excess and yields in the literatures. 
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Figure 2.5 – Enol ethers and esters 
 
The enol ethers and esters were oxidized in two different ways: the non-selective route 
employs meta-chloroperoxybenzoic acid (m-CpBA) to prepare a racemic mixture, followed 
by the removal of the protecting group, if necessary. The enantioselective way involves the 
epoxidation of enols using iminium salt catalysts in the presence of tetraphenylphosphonium 
monoperoxysulfate to achieve α-hydroxy carbonyls (Scheme 2.4). 
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The catalytic cycle is shown above; the epoxidation of enol ethers and esters using iminium salts 
catalyst. 
Scheme 2.4. 
 
2.1 Synthesis of catalysts  
 
Biphenyl, dihydroisoquinoline and binaphthyl moieties were used in the synthesis of 
iminium salt catalysts as backbones. (R)-Bis-bromomethyl-[1,1’]-binaphthylenyl 24 and 
2,2’-bis(bromomethyl) biphenyl 25 (Figure 2.4) were reacted with chiral primary amine 27 
to produce the corresponding biphenyl catalyst 7 and binaphthyl catalyst 9, and 2-(2-
bromomethyl)benzaldehyde 26 was condensed with amine 28 to furnish dihydroisoquinoline 
catalyst 4. 
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Figure 2.4 – Backbone moieties and chiral primary amines. 
 
 
2.1.1 Synthesis of Dihydroisoquinolinium Salt Catalyst 4 
 
The synthesis of iminium catalyst 4 is divided into two parts: the first part is the formation 
of (4S, 5S)-5-amino-6-(4-methylsulfone)-2,2-dimethyl-1,3-dioxane 28 from thiomicamine 
29, and the second part is the formation of 2-(2-bromoethyl)benzaldehyde 26. Methyl 
formate was used to protect the amine group in thiomicamine 29 to give diol 30, followed 
by the addition of 2,2-dimethoxypropane with camphorsulfonic acid to protect diol 31. Then, 
meta-chloroperoxybenzoic acid was added to oxidize the sulfide group followed by 
deprotection of the formyl group using hydrazine monohydrate to give (4S,5S)-5-amino-6-
(4-methylsulfone)-2,2-dimethyl-1,3-dioxane 28 (Scheme 2.3).10  
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29 30 31
32 28  
Reagents and conditions: (i) NaOMe (0.1 equiv), Methyl formate (1.1 equiv.), MeOH, rt; (ii) 2,2-
Dimethoxypropane (5 equiv.), Camphorsulfonic acid (0.1 equiv.),Acetone, 83%; (iii) m-CpBA (3 
equiv.) in DCM, 0 °C, 2 h, 78 %; (iv) hydrazine hydrate (98%), reflux, 3 h, 50%. 
Scheme 2.3 
 
1H NMR data analysis confirmed the presence of each intermediate. The amine protection 
(step 1) using a formyl protecting group led to an observable signal at 8.4 ppm, indicating 
the presence of the amide. Diol protection (step 2) was observed when (2x) CH3 group 
signals were seen at 1.59 ppm. Oxidation of the sulphur atom using m-CPBA (step 3) shifts 
the SMe signal from 2.5 ppm to SO2Me at 3.1 ppm. Deprotection of the amide (step 4) was 
observed using 1H NMR spectrum analysis where the signal at 8.4 ppm disappears. 
The formation of 2-(2-bromoethyl) benzaldehyde 26 was achieved according to the 
procedure of Rieche and Schmitz.13 Bromoaldehyde 26 was obtained from the bromination 
of isochroman 33 and isolated after distillation of the crude mixture (Scheme 2.4).1 
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O O
Br
O
Br
33 34 26
i ii
 
Reagents and conditions: (i): Bromine, cyclohexane, reflux, 15 
min; (ii): HBr, reflux, 10 min, 57% 
Scheme 2.4. 
 
Finally, cyclocondensation of 2-(2-bromoethyl)benzaldehyde 26 with (4S,5S)-5-amino-6-
(4-methylsulfone)-2,2-dimethyl-1,3-dioxane 28 gave the corresponding 
dihydroisoquinolinium bromide salt, and subsequent anion exchange with sodium 
tetraphenylborate yielded iminium salt catalyst 4 as yellow crystals in 54% yield. 
 
O
O
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BPh4
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i,
 
ii
28 4  
 
Reagents and conditions: (i) 26 (1.1 equiv.), EtOH, 0 °C; (ii) NaBPh4 
(1.1 equiv.), MeCN, rt, 54%. 
Scheme 2.5. 
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2.1.2 Synthesis of biphenyl iminium salt catalyst 7 
 
To synthesize biphenyl iminium salt catalyst 7, aminodioxane 27 was prepared from chiral 
(S)-(−)-2-amino-3-phenyl-1-propanediol 35 in three steps (Scheme 2.6).14 Amine 35 was 
dissolved in methanol in the presence of sodium methoxide and methyl formate to furnish 
diol 36, followed by treatment with 2,2-dimethoxypropane in the presence of 
camphorsulfonic acid to obtain N-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-
formamide 37 in 86% yield. The last step towards aminodioxane 27 is the removal of the 
formyl group using hydrazine monohydrate, giving aminodioxane 27 in 86% yield. 
 
O O
NH2
OH OH
NH2
O O
HN
O
OH OH
HN
O
i
35 36 37 27
ii iii
 
Reagents and conditions: (i) NaOMe (0.1 equiv), Methyl formate (1.1 equiv.), MeOH, rt, 12 h; (ii) 
2,2-Dimethoxypropane (5 equiv.), Camphorsulfonic acid (0.1 equiv.), acetone; (iii) hydrazine 
hydrate (98%), reflux, 3 h, 86%. 
Scheme 2.6 
 
The biphenyl backbone of the catalyst was obtained by heating 2,2’-biphenyldimethanol 38 
in hydrobromic acid for 2 h under reflux, which afforded 2,2’-bis(bromomethyl)biphenyl 25 
as colourless crystals in a good yield (Scheme 2.7).15 
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OH
OH
Br
Br
2538
i
 
Reagents and conditions: (i) Hydrobromic acid (48%), reflux, 2 h, 93%. 
Scheme 2.7. 
 
2,2’-bis(Bromomethyl)biphenyl 25 and aminodioxane 27 were dissolved in acetonitrile 
under basic conditions (potassium carbonate) and heated under reflux for 24 h. N-
Bromosuccinimide was added to the biphenyl compound 39 in dichloromethane to afford 
the bromide salt. Finally, the bromide counter ion was exchanged for a tetraphenylborate 
anion by adding sodium tetraphenylborate, yielding the biphenyl iminium salt catalyst 7 
(Scheme 2.8). 2, 3 
 
N
O
O
BPh4Br
Br
N
O
Oi
25 39 7
ii
 
 
Reagents and conditions: (i) aminodioxane 27 (1 equiv.), K2CO3 (2 equiv.), MeCN, reflux, 24 h (ii) 
NBS (1.1 equiv.), CH2Cl2, rt, 1 h; NaBPh4 (1.2 equiv.) in the minimum amount of MeCN, rt, 5 min. 
Scheme 2.8. 
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2.1.3 Synthesis of binaphthalene iminium salt catalyst 9  
 
Binaphthalene catalyst 9 was the final catalyst prepared for our project. The synthesis of this 
catalyst does not need column chromatography and is as rapid as the biphenyl iminium and 
dihydroisoquinolinium salts 7 and 4, respectively. Two possible routes were devised to 
access catalyst 9. The first way started with bromoaldehyde binaphthalene 40 which reacted 
with primary amine 27 and 28 which provided catalysts 9 and 41 (Scheme 2.9).8  
 
N
O
OBr
O
i,
 
ii
BPh4
40 R
9,
 
R
 = H,
 
65%
41, R
 = SO2Me
, 66%  
Reagents and conditions: (i) primary amine 27, 28 (1 equiv.), EtOH, 24 h; (ii) NaBPh4 (1.2 equiv.) 
in the minimum amount of MeCN, rt, 5 min. 
Scheme 2.9. 
 
The second method involves dibromomethyl binaphthalene 24 instead of bromoaldehyde 
binaphthalene 40. The two bromides were substituted with primary amine 27 and 28, 
followed by oxidation of the iminium species and cation exchange (Scheme 2.10).8 
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In this project, the second method was used to prepare binaphthalene iminium salt catalyst 
9 as it was found experimentally easier than the first method.  
 
N
O
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ii
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iii
 
 
Reagents and conditions: (i) primary amine 27, 28 (1 equiv.), K2CO3 (2 equiv.), MeCN, reflux, 24 
h (ii) NBS (1.1 equiv.), CH2Cl2, rt, 1 h; (iii) NaBPh4 (1.2 equiv.) in the minimum amount of 
MeCN, rt, 5 min. 
Scheme 2.10. 
 
 
Dibromomethyl binaphthalene 24 was formed in 3 steps. We started from (R)-(+)-BINOL 
42. Triflation of (R)-(+)-BINOL 42 gave bistriflate 43 in good yield using 2,6-lutidine, triflic 
anhydride and 4-dimethylaminopyridine in dichloromethane. (R)-Dimethylated compound 
44 was afforded by Kumada cross-coupling using a nickel catalyst and methylmagnesium 
bromide.14, 15 Dibromomethyl binaphthalene 24 was obtained through bromination of 
compound 44 using azobisisobutyronitrile (AIBN) and N-bromosuccinimide (NBS), 
furnishing bis(bromomethyl) 24 in 56% yield (Scheme 2.11).9  
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Bri ii iii
42 43 44 24
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OH
 
Reagents and conditions: (i) Tf2O (3 equiv.), DMAP (0.4 equiv.), 2,6-lutidine (3 equiv.), CH2Cl2, 
overnight, –30°C to rt, 92%; (ii) MeMgBr (4 equiv.), Ni(II)Cl dppe, Et2O, 16 h, –30°C to rt, 80%; 
(iii) NBS (2.2 equiv.), AIBN (5 mol%), cyclohexane, reflux, 3 h, 56%. 
Scheme 2.11. 
 
Subsequently, the primary amine 27 was reacted with (R)-bis(bromomethyl)binaphthalene 
24 in the presence of K2CO3 in MeCN to afford the corresponding amine 45. NBS was added 
to oxidize the compound 45 to the iminium species, followed by counter anion exchange 
using sodium tetraphenylborate, to furnish iminium salt catalyst 9 as yellow powder in 49% 
yield (Scheme 2.12).  
 
N
O
OBr
Br
N
O
O
BPh4
i ii
24 45 9  
Reagents and conditions: (i) primary amine 27 (1 equiv.), K2CO3 (2 equiv.), MeCN, reflux, 24 h 
(ii) NBS (1.1 equiv.), CH2Cl2, rt, 1 h; NaBPh4 (1.2 equiv.) in the minimum amount of MeCN, rt, 5 
min, 49%. 
Scheme 2.12. 
2.2 Synthesis of Tetraphenylphosphonium Monoperoxysulphate 11 
(TPPP)  
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Page showed that tetraphenylphosphonium monoperoxysulfate can be used for asymmetric 
epoxidation of olefins with iminium salt catalysts. Tetraphenylphosphonium 
monoperoxysulfate (TPPP) is an oxidant designed for non-aqueous conditions; the oxidant 
commonly employed, Oxone, is used under aqueous conditions.10 In 1994, Di Furia reported 
the preparation of TPPP.18 The procedure for the formation of TPPP is shown below (Scheme 
2.13), affording the product in 69% yield after recrystallization in hexane. 
Tetraphenylphosphonium monoperoxysulfate was formed by anion exchange between 
Oxone and tetraphenylphosphonium chloride. 
 
P
HSO5
P
Cl
i
46 11  
Reagents and conditions: (i): Oxone (1 equiv.), CHCl3:H2O, 10 °C, 0.5 h 
Scheme 2.13. 
 
 
 
 
2.3 Synthesis and epoxidation of enol ethers and esters  
 
As indicated above, we intended to prepare α-hydroxy carbonyls from different ketone 
starting materials. The ketone substrates would be converted into the corresponding enol 
esters or ethers, and oxidation would lead to the corresponding epoxides using m-CpBA and 
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catalysts 7, 9 and 4. In situ ring opening of the epoxide moiety would yield the desired α-
hydroxy carbonyls (Scheme 2.14).  
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Scheme 2.14  
 
 
2.3.1 Synthesis and epoxidation of enol ethers  
 
2.3.1.1 Synthesis of (3,4-(dihydronaphthalen-1-yl)oxy)triisopropylsilane 2217 
 
For the preparation of (3,4-(dihydronaphthalen-1-yl)oxy)triisopropylsilane 22, 3,4-dihydro-
2H-naphthalen-1-one (or α-tetralone) 47 was used as the starting material. Triisopropylsilyl 
triflate was added to a solution of α-tetralone 47 in dichloromethane in the presence of 
triethylamine, affording silyl enol ether 22 in 40% yield (Scheme 2.15).19  
 
O O Si
47 22
i
 
Reagents and conditions: (i): Triisopropylsilyl triflate, triethylamine, CH2Cl2, 40%.  
Scheme 2.15.  
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The racemic α-hydroxy carbonyl 49 was prepared by adding m-CpBA and sodium 
bicarbonate to a solution of (3,4-dihydronaphthalen-1-yl)oxy)triisopropylsilane 22 in 
dichloromethane; 2-((triisopropylsilyl)oxy)-3,4-dihydronaphthalen-1(2H)-one 48 was 
obtained in 89% yield (Table 2.2). Compound 48 was dissolved in methanol and 
camphorsulphonic acid was added to remove the silyl group, forming racemic α-hydroxy 
carbonyl 49.18 Dihydroisoquinolinium salt catalyst 4 was used to prepare the non-racemic 
compound. Silyl enol ether 22, catalyst 4 and TPPP were dissolved in chloroform for 24 h 
followed by the removal of the protecting group. The reaction afforded 2-hydroxy-3,4-
dihydronaphthalen-1(2H)-one 49 in 35 % enantiomeric excess.18  
 
Table 2.2 Epoxidation of (3,4-dihydronaphthalen-1-yl)oxy)triisopropylsilane 22  
 
O Si O
O Si
22 48 49
i
 or ii iii
O
OH
 
Reagents and conditions: (i): m-CPBA (1.5 equiv.), NaHCO3, CH2Cl2,  0°C; (ii) Catalyst 4 (0.1 equiv.), TPPP 
(2 equiv.), chloroform, 0°C; (iii) camphorsulphonic acid (1.1 equiv), methanol. 
Catalyst 
(10 mol%) 
Oxidant 
(2 equiv.) 
Time 
(h) 
Solvent 
Conversiona 
(%) 
eeb 
(%) 
 Abs conf.c 
maj. 
enant. 
-  m-CpBA 2 CH2Cl2 100 - - 
4 TPPP 24 CHCl3 52 35 (+)-(R) 
[a] Estimated by integration of the crude 1H NMR spectrum. [b] Enantiomeric excesses were determined by 
chiral HPLC analysis. (Chiralcel OD-H column using a mixture of isopropanol and hexane as eluent). [c] The 
absolute configuration of 2-hydroxy-3,4-dihydronaphthalen-1(2H)-one 49 was determined by comparison of 
the sign of its specific rotation with that reported in the literature.18 
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2.3.1.2 Synthesis of 2,2-dimethyl-2H-chromen-4-yl)oxy)triisopropylsilane 16  
 
To achieve the synthesis 2,2-dimethyl-2H-chromen-4-yl)oxy)triisopropylsilane 16, 
hydroxyacetophenone 50 was used as the starting material. The cyclization of 
hydroxyacetophenone 50 with acetone and pyrrolidine under reflux for 12 h gave 2,2-
dimethylchroman-4-one 51 in good yield.21 2,2-Dimethyl-2H-chromen-4-
yl)oxy)triisopropylsilane 16 was prepared from 51 using the same reaction conditions as 
above (Scheme 2.16). 
OH
O
O
O
O
O Si
1650 51
i ii
 
 
Reagents and conditions: (i): Pyrrolidine, acetone, EtOH, 12 h (ii): Triisopropylsilyl triflate, 
triethylamine, CH2Cl2, 93%.  
Scheme 2.16. 
 
Enol ether 16 was submitted to the non-selective and the enantioselective reaction conditions 
described in (Table 2.3). α-Hydroxy carbonyl 53 was obtained in 36% ee after 24 h using 
the enantioselective method The absolute configuration of α-hydroxy carbonyl 53 was not 
previously determined in the literature. 
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Table 2.3 Epoxidation of 2,2-dimethyl-2H-chromen-4-yl)oxy)triisopropylsilane 16 
 
Reagents and conditions: (i): m-CPBA (1.5 equiv.), NaHCO3, CH2Cl2, 0°C; (ii): Catalyst 4 (0.1 eq 
uiv.), TPPP (2 equiv.), chloroform, 0°C; (iii): camphorsulphonic acid (1.1 equiv), methanol. 
 
Catalyst  
(10 mol%)  
Oxidant  
(2 equiv.)  
Time  
(h)  
Conv.a 
(%)  
eeb 
(%)  
 
Rotation 
- m-CpBA  2  100  - - 
4  TPPP  24  100 36  (+) 
[a] Estimated by integration of the crude 1H NMR spectrum. [b] Enantiomeric excesses were determined by 
chiral HPLC analysis. (Chiralcel OD-H column using a mixture of isopropanol and hexane as eluent). 
 
 
 
 
2.3.1.3 Synthesis of tert-butyl(3,4-dihydronaphthalen-1-yl)oxy)diphenylsilane 18  
 
To synthesise tert-butyl(3,4-dihydronaphthalen-1-yl)oxy)diphenylsilane 18, α-tetralone was 
added to a solution of potassium hexamethyldisilazide in tetrahydrofuran at –78 °C. tert-
Butylchlorodiphenylsilane was then added to the reaction at –78 °C. The silyl enol ether was 
formed in 45% yield.23 The epoxidation of silyl enol ether 18 was achieved in high 
conversions of 91% and 95 % using catalysts 7 and 9, respectively (Table 2.4).  
 
 
O
O Si
O
O
O Si
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 or ii
O
O
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OSi(Ph)2t
-BuO
47 18
i
 
Reagents and conditions: (i): tert-Butylchlorodiphenylsilane, potassium hexamethyldisilazide, 
tetrahydrofuran, 40%. 
Scheme 2.17. 
 
The enantiomeric excesses obtained for the epoxidation of silyl enol ether 18 were higher 
than the ee obtained for the epoxidation of silyl enol ether 16. One possible reason may 
involve the relative size of the silyl groups. Indeed, enol ether 18 has the bulkier TBDPS 
group attached. 
 
Table 2.4 Epoxidation of tert-butyl (3,4-dihydronaphthalen-1-yl)oxy)diphenylsilane 18 
 
OSi(Ph)2t
-Bu O
OSi(Ph)2t
-Bu
4918 54
i
 or ii iii
O
OH
 
 
Reagents and conditions: (i): m-CPBA (1.5 equiv.), NaHCO3, CH2Cl2, 0°C; (ii) Catalyst 4, 7 (0.1 equiv.), 
TPPP (2 equiv.), chloroform, 0°C; (iii) camphorsulphonic acid (1.1 equiv), methanol. 
 
 
Catalyst  
(10 mol%)  
Time  
(h)  
Conv.a 
(%)  
eeb 
(%)  
 Abs. conf.c maj. 
enant. 
 9 24  95  50  (+)-(R) 
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 7  24  91  52  (+)-(R) 
[a] Estimated by integration of the crude 1H NMR spectrum. [b] Enantiomeric excesses were determined by 
chiral HPLC analysis. (Chiralcel OD-H column using a mixture of isopropanol and hexane as eluent). [c] The 
absolute configuration of 2-hydroxy-3,4-dihydronaphthalen-1(2H)-one 49 was determined by comparison of 
the sign of its specific rotation with that reported in the literature.18 
 
 
2.3.2 Synthesis and epoxidation of enol esters  
 
2.3.2.1 Synthesis of 3,4-dihydronaphthalen-1-yl acetate 19 
 
The synthesis of acetate enol ester 19 was attempted using three different methods. First, we 
used DMAP, a useful nucleophilic catalyst, with acetyl chloride and triethylamine as the 
base. Unfortunately, only starting material was recovered. Next, acetic anhydride was used 
instead of acetyl chloride but the same result was obtained. Finally, another procedure to 
prepare acetate enol ester 19 using para-toluenesulfonic acid and isopropenyl acetate was 
tested. The reaction was reflux for 24 h to allow for acetone removal. The corresponding 
enol acetate was isolated using column chromatography in 76% yield. (Scheme 2.18).24, 25    
 
O
O
O
i
47 19  
Reagents and conditions: (i): isopropenyl acetate, p-toluenesulfonic acid monohydrate, 12 h, 76%. 
Scheme 2.18 
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The racemic 2-hydroxy-3,4-dihydronaphthalen-1(2H)-one 49 had already been prepared 
using silyl enol ether 22. The epoxidation of acetate enol ester 19 was achieved using 
conditions similar to that used to obtain enol ethers 22 and 16 (Catalyst 4, TPPP, CHCl3, 24 
h, 0 °C). However, acetate enol ester 19 was obtained in 66% ee, substantially higher than 
the corresponding oxidation of silyl enol ethers 22 and 16 (35% ee and 36% ee,  
respectively). Another advantage of the synthesis is that it affords α-hydroxy carbonyl 49 
without requiring the protecting group removal step as the acetate group is cleaved during 
the epoxidation step. Subsequently, different solvents were tested, such as acetonitrile, 
dichloromethane and chloroform with catalyst 4 at −30 °C. Acetonitrile and dichloromethane 
led to lower enantiomeric excesses than chloroform when they were used as the reaction 
solvent (Table 2.5).  
 
Table 2.5 Epoxidation of 3,4-dihydronaphthalen-1-yl acetate 19 
O
O
i
19 49
O
OH
 
Reagents and conditions: (i): Catalyst 4, 7 or 9 (0.1 equiv.), TPPP (2 equiv.). 
 
 
Catalyst  
(10 mol%)  
Temp.  
(°C)  
Time  
(h)  
Solvent  
Conv.a 
 (%)  
eeb  
(%)  
Abs conf.c 
maj. 
enant. 
4 0  24  CHCl3  62 66  (–)-(R) 
9 0  48  CHCl3  12  31  (+)-(R) 
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7  0  48  CHCl3  99  88  (+)-(R) 
 4  −30  24  CH2Cl2  62  70  (–)-(R) 
 4  −30  24  MeCN  70  67  (–)-(R) 
 4  −30  24  CHCl3  42 72  (–)-(R) 
9 −30 48 CHCl3 5 - - 
 7 −30  48  CHCl3  95  97  (+)-(R) 
 7 −45  48  CHCl3  95  98  (+)-(R) 
[a] Estimated by integration of the crude 1H NMR spectrum. [b] Enantiomeric excesses were determined by 
chiral HPLC analysis. (Chiralcel OD-H column using a mixture of isopropanol and hexane as eluent). [c] The 
configuration of α-hydroxy carbonyl 49 were assessed by comparison of their specific rotation with literature 
data.24, 25 
 
With the optimum solvent found, catalysts 4, 7 and 9 were tested at 0 °C. Biphenyl catalyst 
7 gave the highest enantiomeric excess and conversion (88% and 99%, respectively). 
Disappointingly, binaphthyl catalyst 9 afforded α-hydroxy carbonyl 49 in 31% ee. It was 
clear that biphenyl catalyst 7 and chloroform provided the best conditions. The temperature 
was lowered in an attempt to increase the enantioselectivity. At 0 °C, α-hydroxy carbonyl 49 
was obtained in 88% ee. As expected, when the temperature was reduced to –30 °C and –45 
°C, α-hydroxy carbonyl 49 was obtained in 97% and 98% ee, respectively (Table 2.5).  
 
2.3.2.2  Synthesis of 3,4-dihydronaphthalen-1-yl diethyl phosphate 14 
 
We then turned our attention to enol phosphates. Enol phosphate 14 was prepared using LDA 
and diethyl phosphorochloridate. LDA was prepared by dissolving diisopropylamine in 
anhydrous THF at –78 °C followed by addition of n-BuLi. Subsequently, the LDA solution 
was added to α-tetralone 47 in THF at –78 °C. The mixture was stirred for 1 h under an argon 
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atmosphere. The solution of diethyl phosphorochloridate was added dropwise at the same 
temperature. Finally, enol phosphate 14 was obtained using column chromatography in 69% 
yield.28 
O P
O
O
O
O
47 14
i
 
Reagents and conditions: (i): Diethyl phosphorochloridate, Lithium diisopropylamide, −78 °C, 69%. 
Scheme 2.19 
 
Chloroform was also chosen as the solvent for enantioselective oxidation of phosphate enol 
ether 14 at different temperatures (0 °C, −30 °C, −50 °C) with catalysts 4 and 7 (Table 2.6).  
Table 2.6 Epoxidation of 3,4-dihydronaphthalen-1-yl diethyl phosphate 14 
O P
O
O
O
4914
i
O
OH
 
Reagents and conditions: (i): Catalyst 4 or 7 (0.1 equiv.), TPPP (2 equiv.), chloroform. 
 
Catalyst  
(10 mol%)  
Temp.  
(°C)  
Time  
(h)  
Conv.a 
(%)  
eeb  
(%)  
 Abs conf.c 
maj. 
enant. 
 4  0  48  45  25  (–)-(R) 
 4 −30 48  22  35  (–)-(R) 
 4 −50 72  -  -  - 
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 7 −30 72 45 90 (+)-(R) 
[a] Estimated by integration of the crude 1H NMR spectrum. [b] Enantiomeric excesses were determined by 
chiral HPLC analysis. (Chiralcel OD-H column using a mixture of isopropanol and hexane as eluent). [c] The 
absolute configuration were determined by comparison of the sign of its specific rotation with that reported in 
the literature.27 
 
 
  
We observed that when the temperature was reduced, the enantiomeric excess increased: for 
example, using catalyst 4 at 0 °C, the product was obtained in 25% ee, while at −30 °C the 
enantiomeric excess was 35% ee. Biphenyl catalyst 7 gave excellent enantiomeric excess of 
90% ee; however, the conversion is lower when compared with acetate enol ester 19.  
 
 
2.3.2.3  Synthesis of 3,4-dihydronaphthalen-1-yl 2,2,2-trifluoroacetate 12  
 
Trifluoroacetate enol ester 12 was prepared using 1-tetralone and trifluoroacetic anhydride 
affording 3,4-dihydronaphthalen-1-yl 2,2,2-trifluoroacetate 12 in excellent yield (Scheme 
2.20). We were delighted to find that the epoxidation of 12 proceeded in 90% ee when the 
reaction was performed in chloroform with catalyst 7 at 0°C, higher than catalysts 4 and 9 
using the same reaction conditions (Table 2.7). 
O
O
O
47 12
i
CF3
 
Reagents and conditions: (i): trifluoroacetic anhydride, p-toluenesulfonic acid monohydrate, 12 h 
(ii): Catalyst 4, 7 and 9 (0.1 equiv.), TPPP (2 equiv.), 91%. 
Scheme 2.20. 
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Table 2.7 Epoxidation of 3,4-dihydronaphthalen-1-yl 2,2,2-trifluoroacetate 12. 
O
O
4912
i
CF3 O
OH
 
Reagents and conditions: (i): Catalyst 4, 7 and 9 (0.1 equiv.), TPPP (2 equiv.), chloroform, 0°C. 
 
Catalyst  
(10 mol%)  
Time  
(h)  
Conv.a 
(%)  
eeb 
(%)  
 Abs conf.c 
 maj. 
enant. 
 4 24  23  54  (–)-(R) 
 7 24  65  90  (+)-(R) 
 9 24  63  43  (+)-(R) 
[a] Estimated by integration of the crude 1H NMR spectrum. [b] Enantiomeric excesses were determined by 
chiral HPLC analysis. (Chiralcel OD-H column using a mixture of isopropanol and hexane as eluent). [c] The 
absolute configuration were determined by comparison of the sign of its specific rotation with that reported in 
the literature.27 
 
2.3.2.4 Synthesis of 3,4-dihydronaphthalen-1-yl benzoate 20 
 
The enol benzoate 20 was obtained by addition of perchloric acid into a solution of benzoic 
anhydride and 1-tetralone in hexane. (Scheme 2.21). 30 
OO Ph
O
47 20
i
 
Reagents and conditions: (i): benzoic anhydride, perchloric acid, hexane, r.t., 2 h, 26%. 
Scheme 2.21 
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The epoxidation of enol benzoate 20 was achieved in good enantioselectivities of 89%, 54% 
and 43% using catalysts 7, 4 and 9, respectively. 
 
Table 2.8 Epoxidation of 3,4-dihydronaphthalen-1-yl benzoate 20. 
O Ph
O
4920
i
O
OH
 
Reagents and conditions: (i): Catalyst 4, 7 and 9 (0.1 equiv.), TPPP (2 equiv.), chloroform, 0°C. 
 
Catalyst  
(10 mol%)  
Time  
(h)  
Conv.a 
(%)  
eeb 
(%)  
 Abs conf.c 
 maj. 
enant. 
 4 24  23  54  (–)-(R) 
 7 24  35  89  (+)-(R) 
 9 24  33  43  (+)-(R) 
[a] Estimated by integration of the crude 1H NMR spectrum. [b] Enantiomeric excesses were determined by 
chiral HPLC analysis. (Chiralcel OD-H column using a mixture of isopropanol and hexane as eluent). [c] The 
absolute configuration were determined by comparison of the sign of its specific rotation with that reported in 
the literature.27 
 
 
 
2.3.2.5  Enol Acetate synthesis  
 
After we tested different enol esters we found that the epoxidation of enol acetate 19 gave 
high enantioselectivity using iminium salt catalysts. Moreover, enols acetate 19 provided 
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high conversion, up to 99%. In order to expand the methodology, enol acetates from different 
substrates, such as 1-indanone 55, propiophenone 57, 2-tetralone 59 and 1-benzosuberone 
61, were prepared.  
 
Table 2.9: synthesis of different enol acetates 
R
R
O
R
R
O
O
 
Reagents and conditions: (i): isopropenyl acetate, p-toluenesulfonic acid monohydrate, 12 h. 
 
Substrates Enols Yield 
O
55
 
OAc
21
 
80% 
O
57  
OAcOAc
23  
73% 
O
59  13
OAc
 
71% 
O
61  
OAc
15  
95% 
 
Biphenyl catalyst 7 with TPPP and chloroform as the solvent were used for the epoxidation 
of acetate enol esters 21, 23 and 15. All the enol esters provided high conversion and high 
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enantioselectivity. Enol acetate 23 was isolated as an inseparable mixture of two isomers, E 
and Z in a 10:1 ratio. The mixture of (E)-1-phenylprop-1-en-1-yl acetate and (Z)-1-
phenylprop-1-en-1-yl acetate 23, catalyst 7 and TPPP were dissolved in chloroform for 72 h 
to afford (S)-2-hydroxy-1-phenylpropan-1-one 58 in 57 % enantiomeric excess. The 
presence of a mixture could explain the low enantioselectivity (57%) observed.   
 
Table 2.10 Epoxidation of different acetate enol esters by catalyst 7.  
 
Enol 
α-Hydroxy-
carbonyl 
Oxidant 
Temp. 
(°C) 
Time 
(h) 
Solvent 
Conv.a 
(%) 
ee 
(%) 
Abs conf. 
maj. 
enant. 
21 
56
O
OH
 
m-CpBA 0 4 CH2Cl2 100 - - 
TPPP −30 48 CHCl3 70 80b (–)-(S)e 
23 
58
OH
O
 
m-CpBA 0 3 CH2Cl2 100 - - 
TPPP −30 72 CHCl3 95 57c (–)-(S)f 
15 
62
O OH
 
m-CpBA 0 3 CH2Cl2 85 - - 
TPPP 0 24 CHCl3 99 87b (+)-(S)g 
TPPP −30 48 CHCl3 95 92b (+)-(S)g 
[a] Estimated by integration of the crude 1H NMR spectrum. [b] Enantiomeric excesses were determined by 
chiral HPLC analysis. (Chiralcel OD-H column using a mixture of isopropanol and hexane as eluent). [c] 
Enantiomeric excesses were determined by chiral HPLC analysis. (XD 6 Eurocel 01 column using a mixture 
of isopropanol and hexane as eluent).[e] The configuration of the (S)-2-hydroxy-2,3-dihydro-1H-inden-1-one 
56 were assessed by comparison of their specific rotation with literature data.24, 25 [f] The assignment of the 
absolute configuration to (S)-2-hydroxy-1-phenylpropan-1-one 58 was confirmed by Tsuchihashi and co-
workers.29  [g] The absolute configuration of (S)-6-hydroxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one 62 
was determined via 1H-NMR analysis of Mosher's esters of the products according to the protocol of Hoye and 
coworkers.30,31 
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2.3.2.6    Synthesis of 1-(2,2,2-trifluoroacetyl)-1,2-dihydroquinolin-4-yl acetate 17 
 
We utilized our methodology for the preparation of 3-hydroxy-1-(2,2,2-trifluoroacetyl)-2,3-
dihydroquinolin-4(1H)-one 68 through epoxidation of acetate enol ester 17. To obtain 1-
(2,2,2-trifluoroacetyl)-1,2-dihydroquinolin-4-yl acetate 17, aniline 65 was targeted. 
Bromopropanoyl chloride was added to aniline with potassium carbonate in 
dichloromethane, which yielded 3-bromo-N-phenylpropanamide 64.34 Compound 64 was 
dissolved in dimethylformamide and a strong base was added to afford β-lactam 65.35 2,3-
Dihydroquinolin-4(1H)-one 66 was prepared by a Fries-type rearrangement.36 Subsequently, 
trifluoroacetic anhydride was added dropwise at 0 °C in the presence of triethylamine to 
protect the amine, which yielded 1-(2,2,2-trifluoroacetyl)-2,3-dihydroquinolin-4(1H)-one 
67 in 78% yield (Scheme 2.22).36 Finally, acetate enol ester 17 was prepared using para-
toluenesulfonic acid and isopropenyl acetate. 
NH2
H
N
O
N
H
O
N
O
N
O
N
O
OH
i ii iii
63 64 65 66
67 6817
iv v vi
N
O
Br
CF3O
CF3O C
F3O
O
 
Reagents and conditions: (i): 3-Bromopropanoyl chloride, K2CO3, CH2Cl2, 0 °C, 3h, 63%. (ii): Sodium tert-
butoxide, dimethylformamide, 55%. (iii): Trifluoromethanesulfonic acid, 1,2-dichloroethane, 86%. (iv): 
Trifluoroacetic anhydride, triethylamine, dichloromethane, 4h, 78%. (v): isopropenyl acetate, p-
toluenesulfonic acid monohydrate, 12 h, 41% (vi): Catalyst 4 (0.1 equiv.), TPPP (2 equiv.), chloroform. 
Scheme 2.22. 
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The racemic 3-hydroxy-1-(2,2,2-trifluoroacetyl)-2,3-dihydroquinolin-4(1H)-one 68 was 
prepared using meta-chloroperoxybenzoic acid, and, using our best conditions, compound 
68 was obtained in 70% ee (Table 2.11). 
 
 
Table 2.11 Epoxidation of 1-(2,2,2-trifluoroacetyl)-1,2-dihydroquinolin-4-yl acetate 17 
 
N
O
N
O
OH
6817
i
CF3O C
F3O
O
 
Reagents and conditions: (i): Catalyst 7 (0.1 equiv.), TPPP (2 equiv.), chloroform. 
 
Catalyst  
(10 mol%)  
Oxidant  
(2 equiv.)  
Temp.  
(°C)  
Time  
(h)  
Solvent  
Conv.a 
(%)  
eeb  
(%)  
 
Rotation. 
-  m-CpBA  0  2 CH2Cl2  80 - - 
 7  TPPP  −30  72 CHCl3  65 70 (–) 
[a] Estimated by integration of the crude 1H NMR spectrum. [b] Enantiomeric excesses were determined by 
chiral HPLC analysis. Measured by chiral HPLC (XD 6 Eurocel 01 column using a mixture of isopropanol and 
hexane as eluent). 
 
 
2.3.2.7   Synthesis of (-)Tatarinoid B 74 
 
(−)-Tatarinoids A, B and C are three natural products of 19 compounds that have been 
isolated from the rhizome of the plant Acorus tatarinowii. (−)-Tatarinoids are used for the 
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treatment of central nervous system diseases in traditional Chinese medicine. For instance, 
in China, it is believed to improve memory and learning.37, 38 
 
 
O
O
O
O
OHO
O
O
OH
O O
O
O
O
O
O
OH
A B C  
Figure 2.7 - Tatarinoids. 
 
The racemic Tatarinoid B was obtained by treatment of 2,4,5-trimethoxybenzaldehyde 71  
with Wittig ylide 70 which formed from the reaction between (1-
methoxyethyl)triphenylphosphonium salt 69 and n-BuLi (Scheme 2.23).39, 40 
 
O
O
O
O
O
O
O
OH
PPh3
MeMeO
H
O
PPh3
MeMeO
BF4
n-BuLi,
 -78
 °C
20
 min,
 
THF
-78
 °C THF
 
30
 min
(±)
-Tatarinoid
 
B
 72
69 70 71
 
Scheme 2.23: Synthesis of (±)-Tatarinoid B 72. 
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The reaction between 2,4,5-trimethoxybenzaldehyde 71 and acetaldehyde using a chiral 
triazolium salt 73 as a catalyst formed (-)-Tatarinoid B 74 in one step (Scheme 2.24).41, 42 
 
O
O
O
H
O N
N
N
FF
F F
F
Ph
OHPh
BF4
O
Me H,
 
Cs2CO3
, THF
 , rt
O
O
O
O
OH
(
-
)
-Tatarinoid
 
B
73
7471  
 
Scheme 2.24: Synthesis of (-)-Tatarinoid B 74. 
 
We planned to synthesize tatarinoid A and B. In the synthesis of tatarinoid B 74, our initial 
strategy was to obtain enol acetate 75 using a Wittig or Horner-Wadsworth-Emmons 
reaction from 2,4,5-trimethoxybenzaldehyde. 
 
 
O
O
O
O
O
O
O
O O
O
O
O
OH
R3P O
O
75 74
O
 
Scheme 2.25: Strategy towards tatarinoid B 
 
The first route involved using the Wittig reaction to allow us to make enol acetate 75. We 
have used triphenylphosphine with 1-bromoethyl acetate 76 to generate the corresponding 
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phosphonium salt to react with benzaldehyde, but unfortunately the reaction was 
unsuccessful and we were unable to isolate the Wittig salt (Scheme 2.26).43 
 
  
Br O
O
Ph3P O
OB
r
76 77
i
 
Reagents and conditions: (i): triphenylphosphine, toluene. 
Scheme 2.26 
 
In the second route, the Arbuzov reaction was used to prepare phosphonate 78 to replace 
phosphonium salt 77. 1-(Diethoxyphosphoryl)ethyl acetate 78 was prepared by treating 1-
bromoethyl acetate with triethylphosphite.33 A Horner-Wadsworth-Emmons reaction was 
attempted between benzaldehyde 71 and 1-(diethoxyphosphoryl)ethyl acetate 78 to furnish 
the enol acetate 75, but no reaction occurred and the starting material was recovered (Scheme 
2.27).44, 45 
 
O
O
O
O
OO
O
O
Br O
O
P
O O
O
O
O
O
7576 78 71
i ii
 
 
Reagents and conditions: (i): triethylphosphite, 45% (ii): Potassium tert-butoxide, tetrahydrofuran. 
Scheme 2.27 
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Due to the failure of the Wittig and HWE routes to enol acetate 75, a longer synthesis was 
devised to access tatarinoid B 74 (Scheme 2.28). 
 
O
O
O
O O
O
O
O O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
OH
71 79 80
8275
O
O
O
OH
81
74
O
 
Scheme 2.28 
 
1,2,4-Trimethoxy-5-(2-methoxyvinyl)benzene 79 was obtained during the reaction between 
methoxymethyl triphenylphosphonium chloride  and 2,4,5-trimethoxybenzaldehyde 71 in 
presence of n-butyllithium using anhydrous tetrahydrofuran as the solvent.46 
 
O
O
O
O
71
i
O
O
O
75
O
O
O
O
O
 
Reagents and conditions: (i): methoxymethyl triphenylphosphonium chloride, n-butyllithium, 
anhydrous tetrahydrofuran, 65%.  
Scheme 2.29 
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Following this, an aqueous HCl solution was added to compound 79, which furnished the 
aldehyde 80 in good yield (75%).47 The aldehyde 80 was converted to the secondary alcohol 
81 by the addition of methyllithium (Scheme 2.30).48 
 
 
O
O
O
O O
O
O
O
79 80
O
O
O
OH
81
i ii
 
 
Reagents and conditions: (i): aqueous HCl, tetrahydrofuran, reflux, 5 h, 75%. (ii): MeLi, anhydrous 
tetrahydrofuran, 0 °C, 30 min. 
Scheme 2.30 
 
We attempted to oxidize the alcohol moiety using pyridinium chlorochromate but the 
reaction did not produce our target 82.  
 
 
O
O
O
O
82
O
O
O
OH
81
ii
O
O
O
O
83
O
 
Reagents and conditions: (i): Pyridinium chlorochromate, dichloromethane. 
Scheme 2.31 
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Instead, we obtained 1-(2,4,5-trimethoxyphenyl)propane-1,2-dione 83, which means 
pyridinium chlorochromate oxidized both the secondary alcohol and the benzylic methylene. 
1-(2,4,5-Trimethoxyphenyl)propane-1,2-dione 83 was identified by NMR spectra analysis. 
Analysis of the 1H NMR spectrum did not exhibit signals corresponding to the methylene 
protons and two signals corresponding to carbonyl carbon (195 and 200 ppm, corresponding 
to two ketone moieties) were observed when the 13C NMR spectrum was analysed. To solve 
this problem, we will try in future to oxidize the secondary alcohol moiety in compound 81 
using the Swern oxidation. If the reaction does not work we are going to synthesize 2,4,5-
Trimethoxyphenylacetone 82 in two steps from commercially available 2,4,5-
trimethoxybenzaldehyde 71 (Scheme 2.32).49 
 
MeO
MeO OMe
CHO
EtNO2
MeCO2NH4
reflux,
 
45
 min
Fe,
 
FeCl3, HCl
Water
 
/Toluene
 
20/80
reflux,
 
6h
MeO
MeO OMe
NO2
MeO OMe
O
8271 84  
 
Scheme 2.32: Synthesis of 2,4,5-Trimethoxyphenylacetone 82. 
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2.4 Summary of the results  
 
 
Catalyst 
(10 mol%) 
Enol 
Temp 
(°C) 
Time 
(h) 
Solvent 
 
Product Conversion 
 (%) 
ee 
(%) 
 
Abs conf. 
maj. 
enant. 
N
O
O
MeO2S
BPh4
 
O Si
 
0 24 CHCl3 
 
O
OH
 
52 35 
 
 
(+)-(R)20 
N
O
O
BPh4
 
O
O
 
-30  48  CHCl3 
 
O
OH
 
70 80 
 
 
(–)-(S)27 
N
O
O
BPh4
 
O
O
F
F
F
 
0 24 CHCl3 
 
O
OH
 
65 90 (+)-(R)
 26 
N
O
O
MeO2S
BPh4
 
O
O
 
0  24  CHCl3  
 
O
OH
 
62 66  
 
 
(–)-(R)26 
N
O
O
BPh4
 
O
O
 
-30  72 CHCl3 
 
OH
O
 
95  57 
 
 
(–)-(S)31 
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BPh4
N
O
O
 
O
O
 
0  48  CHCl3  
 
O
OH
 
12  31  
 
 
(+)-(R)26 
N
O
O
BPh4
 
O
O
 
0  24  CHCl3 
 
O OH
 
99  87  
 
 
(+)-(S)32 
N
O
O
BPh4
 
O
O
 
0  48  CHCl3  
 
O
OH
 
99  88  
 
 
(+)-(R)26 
N
O
O
MeO2S
BPh4
 
O
O
 
-30  24  CH2Cl2  
 
O
OH
 
62  70  
 
 
(–)-(R)26 
N
O
O
BPh4
 
N
O
O
F
F
F
O
 
-30  72 CHCl3 
 
N
O
OH
CF3O  
65 70 
 
 
     (–) 
N
O
O
MeO2S
BPh4
 
O
O
 
-30  24  MeCN  
 
O
OH
 
70  67  
 
 
(–)-(R)26 
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N
O
O
MeO2S
BPh4
 
O
O
 
-30  24  CHCl3  
 
O
OH
 
42 72  
 
 
(–)-(R)26 
BPh4
N
O
O
 
O
O
 
-30  48  CHCl3 
 
O
OH
 
5  - 
 
 
       - 
N
O
O
BPh4
 
O
O
 
-30  48  CHCl3 
 
O
OH
 
95  97  
 
 
(+)-(R)26 
N
O
O
BPh4
 
O
O
 
-45  48 CHCl3 
 
O
OH
 
95  98  
 
 
(+)-(R)26 
N
O
O
MeO2S
BPh4
 
O P
O
O
O
 
-50  72  CHCl3 
 
O
OH
 
-  -  - 
BPh4
N
O
O
 
OSi(Ph)2t Bu
 
0  24  CHCl3 
 
O
OH
 
95  50  (+)-(R)
20 
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N
O
O
BPh4
 
OSi(Ph)2t Bu
 
0  24  CHCl3 
 
O
OH
 
91  52  (+)-(R)20 
N
O
O
MeO2S
BPh4
 
O
O
F
F
F
 
0 24 CHCl3 
 
O
OH
 
23 54 (–)-(R)
26 
N
O
O
BPh4
 
O
O
 
-30  48  CHCl3 
 
O OH
 
95  92  
 
 
(+)-(S)32  
BPh4
N
O
O
 
O
O
F
F
F
 
0 24 CHCl3 
 
O
OH
 
63 43 (+)-(R)
26 
N
O
O
MeO2S
BPh4
 
O
O
 
0  24  CHCl3 
 
O
OH
 
23  54  
 
 
(–)-(R)27 
N
O
O
BPh4
 
O
O
 
0  24  CHCl3 
 
O
OH
 
35  89  
 
 
(+)-(R)27 
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BPh4
N
O
O
 
O
O
 
0  24  CHCl3 
 
O
OH
 
33  43  (+)-(R)
27 
N
O
O
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O P
O
O
O
 
0  48  CHCl3 
 
O
OH
 
45  25  (–)-(R)29 
N
O
O
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O P
O
O
O
 
-30  48  CHCl3 
 
O
OH
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29 
N
O
O
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 O
O Si
 
0 24 CHCl3 
 
 
O
O
OH
 
100 36 
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O P
O
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-35 72 CHCl3 
 
O
OH
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2.5 Conclusion and future work 
At the first of this work, we challenged ourselves to prepare a number of enantiomerically 
enriched α-hydroxy carbonyls by epoxidation of enol ethers and esters (Scheme 2.30).  
 
 
Scheme 2.30 
 
We believed we achieved that goal by using 6-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-
yl)-5H-dibenzo[c,e]azepin-6-ium catalyst 7, with acetate enol esters 15, 17, 19, 21 and 23. 
From our research, it is clear that acetate enol esters provided high enantioselectivity (up to 
R
O
R
O
R R
R
R
O
R
O
R
R
O
R
OH
R
O
R
R
O
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98% ee) and achieved high conversions up to 99%. Our results are good comparing with 
some results in the literature. For example Shi reported good enantioselective epoxidation 
method for enol esters using fructose derived ketone 17 as catalyst and Oxone as oxidant. 
Shi produced hydroxy ketones up to 91% ee and 66% conversions.49 
 
O
OO
O
OO
17  
 
In our method, the enantioselectivity of the reaction was influenced by a variety of reaction 
conditions, especially temperature, solvent, the structure of the iminium salt catalyst and the 
structure of the substrates. The best solvent was chloroform. It was found that lowering the 
reaction temperature increases the enantiomeric purity of the products. Catalyst (7) is one of 
the most active iminium salt catalysts that we have tested. It is also one of the most 
enantioselective iminium salt epoxidation catalysts ever reported. 
 
In future, because of our encouraging results, it could be possible to generate different natural 
products with our methodology for the epoxidation of enols. 
 
 
N
O
O
BPh4
catalyst
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3.0 Experimental 
 
3.1 General experimental details 
 
3.1.1 Physical Characterisation and Spectroscopic Techniques 
 
Infrared spectra were acquired using a Perkin Elmer System 2000 FT-IR spectrophotometer. 
Solid samples were run as nujol mulls or as thin films of their solution in dichloromethane 
on sodium chloride plates. Liquid samples were run neat. 
 
1H and 13C NMR spectra were measured respectively at 400.13 and 100.62 MHz using 
Varian Unity Plus (400 MHz) spectrometer, at 300.05 and 75.45 MHz using a Varian Gemini 
200 (300 MHz) instrument, at 400.13 and 100.03 MHz using a 400 MHz Bruker Avance III 
2 channel nanobay NMR spectrometer, or at 500.21 and 125.05 MHz using a Bruker Avance 
III 500 MHz NMR spectrometer. Multiplicities in the NMR spectra are described as: s = 
singlet, d = doublet, dd = doublet of doublets, ddd = doublet of doublet of doublets t = triplet, 
td = triplet of doublets, q = quartet, sept. = septet, m = multiplet, br = broad; coupling 
constants are reported in Hz. The solvent used for NMR spectroscopy was deuteriated 
chloroform unless stated otherwise, using the solvent peak as the reference. Chemical shifts 
are given in parts per million (ppm) and J values are given in Hertz (Hz). 
 
High resolution mass spectra were obtained from the EPSRC Mass Spectrometry Service at 
the University of Swansea. Melting points were recorded using a Büchi B- 545 melting point 
instrument and are reported uncorrected. Optical rotation values were measured with a 
Bellingham and Stanley ADP-440 instrument, operating at λ=589 nm, corresponding to  
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the sodium D line at the temperatures indicated. The solvents used for these measurements 
were of spectrophotometric grade. The solutions for these measurements were prepared in 
volumetric flasks for maximum accuracy of the volume of solvent used. 
 
Enantiomeric excesses were determined by chiral high performance liquid chromatography. 
HPLC samples were prepared by using silica gel preparative TLC plates. Data was recorded 
using a Hitachi Elite LaChrom instrument fitted with a L2400 UV detector (256 nm unless 
stated otherwise), L2300 column oven, L2200 autosampler, L2130 pump. Chiral HPLC 
traces were run using two different chiral stationary phase columns: XD 6 Eurocel 01, 
5μm,(derivatized cellulose poysaccharide) and Chiracel OD-H 5μm (Cellulose tris 3,5-
dimethylphenylcarbamate coated on 5μm silica-gel).1,2 All HPLC samples were run using a 
mixture of hexane and isopropanol as the eluent. 
 
All the starting materials and reagents were bought from Alfa Aesar and Sigma Aldrich. 
Et2O and THF were dried over sodium and benzophenone and distilled; toluene was dried 
over sodium wire and distilled. 
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3.2 Individual experiments 
 
 
3.2.1  General procedure for the synthesis of acetate enol esters:3  
 
R
R
O
R
R
O
O
 
 
The ketone, isopropenyl acetate (100 mL) and p-toluenesulfonic acid monohydrate (0.1 
equiv) were placed in round bottomed flask fitted with a Dean-Stark apparatus. The mixture 
was heated overnight to remove acetone continuously. The mixture was poured into a two-
layer solution of aqueous saturated NaHCO3 (50 mL) and diethyl ether (100 mL). The 
organic phase was separated and the aqueous layer was extracted with diethyl ether (3 × 100 
mL). The combined ethereal solutions were washed with aqueous saturated NaHCO3 and 
aqueous saturated NaCl, dried over anhydrous MgSO4, filtered and the solvents were 
removed under reduced pressure. The corresponding enol acetate was isolated by column 
chromatography on silica gel (eluent: hexanes/ethyl acetate 5:1) to give the desired 
compound.  
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3.2.1.1   3,4-Dihydronaphth-1-yl acetate:4 
 
 
O
O
O
 
 
Prepared according to the general procedure for the synthesis of acetate enol esters using 1-
tetralone (2.5 g, 17 mmol), isopropenyl acetate (100 mL) and p-toluenesulfonic acid 
monohydrate (0.3 g, 0.1 equiv., 1.7 mmol) to give the desired product as a colorless oil (2.4 
g, 75%). νmax (film)/cm−1 3100, 2900, 1740, 1650, 1570, 1200; 1H NMR (400 MHz, CDCl3) 
δ 7.21 – 7.10 (m, 4H), 5.73 (t, J = 4.7 Hz, 1H), 2.89 (t, J = 8.1 Hz, 2H), 2.53 – 2.43 (m, 2H), 
2.32 (s, 3H); 13C NMR (100 MHz, CDCl3) δ  169.2, 145.6, 136.3, 130.1, 128.6, 127.8, 126.2, 
120.4, 115.1, 26.9, 23.4, 20.3.                                                                                                                          
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3.2.1.2   6,7-Dihydro-5H-benzo[7]annulen-9-yl acetate:5 
 
O
O
O
 
 
Prepared according to the general procedure for the synthesis of acetate enol esters using 1-
benzosuberone (2.5 g, 15 mmol), isopropenyl acetate (100 mL) and p-toluenesulfonic acid 
monohydrate (0.26 g, 0.1 equiv., 1.5 mmol) to give the desired product as a colorless oil (3.0 
g, 95%). νmax (film) /cm−1: 2930, 2858, 1755; 1H NMR (500 MHz, CDCl3) δ 7.42 (d, J = 6.3 
Hz, 1H), 7.32 – 7.25 (m, 3H), 5.91 (t, J = 6.2 Hz, 1H), 2.92 (t, J = 1.7 Hz, 2H), 2.24 (s, 3H), 
2.23 – 2.19 (m, 2H), 2.16 – 2.10 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 169.6, 146.0, 
141.9, 134.6, 129.2, 128.2, 126.1, 125.5, 119.7, 33.8, 31.3, 25.4, 20.9. 
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3.2.1.3  3,4-Dihydronaphthalen-2-yl acetate:6 
 
O O O
 
 
Prepared according to the general procedure for the synthesis of acetate enol esters using 2-
tetralone (2.5 g, 17 mmol), isopropenyl acetate (100 mL) and p-toluenesulfonic acid 
monohydrate (0.3 g, 0.1 equiv., 1.7 mmol) to give the desired product as a colourless oil (2.3 
g, 71%). νmax (film) /cm−1: 3018, 2800, 1759; 1H NMR (500 MHz, CDCl3) δ 7.19 – 7.12 (m, 
3H), 7.04 (d, J = 6.6 Hz, 1H), 6.25 (s,1H), 3.03 (t, J = 8.3 Hz, 2H), 2.55 (t, J = 8.3 Hz, 2H), 
2.23 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 169.0, 150.9, 133.2, 127.2, 126.8, 126.6, 126.5, 
126.3, 114.7, 28.5, 26.3, 21.1.  
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3.2.1.4  1H-Inden-3-yl acetate:7 
 
O
O
O
 
 
Prepared according to the general procedure for the synthesis of acetate enol esters using 1-
indanone (2.5 g, 19 mmol), isopropenyl acetate (100 mL) and p-toluenesulfonic acid 
monohydrate (0.3 g, 0.1 equiv., 1.9 mmol) to give the desired product as a yellow oil  (2.66 
g, 80%). νmax (film)/cm−1: 2991, 1700, 1450, 1200; 1H NMR (500 MHz, CDCl3) δ 7.51 (d, J 
= 6.5 Hz, 1H), 7.44 – 7.30 (m, 3H), 6.42 (t, J = 2.3 Hz, 1H), 3.47 (d, J = 2.4 Hz, 2H), 2.39 
(s, 3H); 13C NMR (126 MHz, CDCl3) δ 168.2, 149.1, 141.8, 139.1, 126.3, 125.7, 124.1, 
118.1, 115.5, 35.0, 21.1.  
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3.2.1.5 1-Phenylprop-1-enyl acetate: 8 
 
O
O
O
 
 
Prepared according to the general procedure for the synthesis of acetate enol esters using 
propiophenone (2.5 g, 18 mmol), isopropenyl acetate (100 mL) and p-toluenesulfonic acid 
monohydrate (0.3 g, 0.1 equiv., 1.8 mmol) to give the desired product as a yellow oil (2.4 g, 
73%). νmax (film) /cm−1: 3000, 1696, 1500; 1H NMR (500 MHz, CDCl3) δ 7.45 – 7.31 (m, 
5H), 7.31 – 7.29 (m, 0.5H), 5.93 (q, J = 7.0 Hz, 1H), 5.57 (q, J = 7.4 Hz, 0.1H),  2.34 (s,3H), 
2.18 (s, 0.3H), 1.85 (d, J = 7.4 Hz, 0.3H),  1.75 (d, J = 7.0 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 168.6, 146.9, 146.2, 128.4, 128.0, 124.2, 112.6, 20.6, 11.5.  
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3.2.1.6  3,4-Dihydronaphthalen-1-yl 2,2,2-trifluoroacetate:9 
 
O
O
O
F
F
F
 
 
 
Prepared according to the general procedure for the synthesis of acetate enol esters using 1-
tetralone (1:0 g, 6.8 mmol), trifluoroacetic anhydride (50 mL) and p-toluenesulfonic acid 
monohydrate (0.1 g, 0.1 equiv, 0.6 mmol) to give the desired product as a yellow oil (1.5 g, 
91%). νmax (film) /cm−1; 2944, 2838, 1700; 1H NMR (500 MHz, CDCl3) δ 7.29 – 7.20 (m, 
3H), 7.13 (d, J = 6.7 Hz, 1H), 5.96 (t, J = 4.7 Hz, 1H), 2.93 (t, J = 8.2 Hz, 2H), 2.57 – 2.50 
(m, 2H); 13C NMR (126 MHz, CDCl3) δ 144.8, 136.3, 128.7, 128.6, 127.8, 126.7, 120.3, 
115.1 (q, CF3, J = 298 Hz), 30.9, 27.1, 21.9;  
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3.2.2   3-Bromo-N-phenylpropanamide:10, 11 
 
NH2
H
N
O
Br
 
 
Aniline (1.8 mL, 20 mmol) and K2CO3 (3.3 g, 24 mmol) were suspended in CH2Cl2 (20 mL) 
at 0 °C. 3-Bromopropanoyl chloride (2.5 mL, 24 mmol) was added dropwise. The mixture 
was stirred at 0 °C for 30 minutes and allowed to reach room temperature for another 3 h. 
The reaction was quenched with water and extracted with EtOAc three times. The combined 
organic layers were evaporated under reduced pressure, and the residue was recrystallized 
from a mixture of petroleum ether/EtOAc in a 1:1 ratio to afford 3-bromo-N-
phenylpropanamide as colourless crystals (2.8g, 63%). mp 120 °C; νmax (film)/cm−1: 3200, 
3000, 1657; 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 7.9 Hz, 2H), 7.37 (t, J = 7.8 Hz, 2H), 
7.17 (t, J = 7.4 Hz, 1H), 3.75 (t, J = 6.6 Hz, 2H), 2.98 (t, J = 6.6 Hz, 2H); 13C NMR (126 
MHz, CDCl3) δ 168.3, 137.4, 129.0, 124.7, 120.3, 40.5, 27.1. 
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3.2.3   1- Phenylazetidin-2-one:10, 11 
 
 
H
N
O
Br
N
O
 
 
3-Bromo-N-phenylpropanamide (2.8 g, 12.2 mmol) was dissolved in dimethylformamide 
and the reaction was cooled to 0 °C. Sodium tert-butoxide (1.28 g, 13.0 mmol) was added in 
one portion, and the mixture was allowed to reach room temperature gradually. The reaction 
was quenched with water after 3 h and extracted with EtOAc. The combined organic layers 
were evaporated under reduced pressure, and the residue was recrystallized from a hot 
mixture of petroleum ether/EtOAc in a 1:1 ratio to afford 1- phenylazetidin-2-one as a 
colourless solid (1 g, 55%). mp 80 °C [Lit.11 mp 78-80 °C]; 1H NMR (500 MHz, CDCl3) δ 
7.41 – 7.07 (m, 5H), 3.63 (t, J = 4.5 Hz, 2H), 3.11 (t, J = 4.5 Hz, 2H). 13C NMR (126 MHz, 
CDCl3) δ 164.5, 138.5, 129.1, 123.8, 116.1, 38.0, 36.0.  
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3.2.4  2,3-Dihydroquinolin-4(1H)-one:12 
  
N
O
N
H
O
 
1-phenylazetidin-2-one (0.82 g, 5.5 mmol) was dissolved in 1,2-dichloroethane (30 mL) and 
the solution was cooled to 0 °C. Trifluoromethanesulfonic acid (0.83 g, 5.5 mmol) was added 
dropwise to the stirred solution at 0 °C. The mixture was allowed to reach room temperature 
and stirred for 15 minutes. Water (30 mL) was added and the aqueous phase was extracted 
with dichloromethane. The combined organic phases were dried over anhydrous Na2SO4, 
filtered and concentrated under reduced pressure to give the desired product as colourless oil  
(0.7 g, 86%). νmax (film)/cm−1: 3300, 2900, 1655;  1H NMR (500 MHz, CDCl3) δ 7.89 (dd, 
J = 8.0, 1.3 Hz, 1H), 7.36 – 7.30 (m, 1H), 6.80 – 6.75 (m, 1H), 6.71 (d, J = 8.2 Hz, 1H), 3.62 
(t, J = 4.6 Hz,  2H), 2.74 (t, J = 4.6 Hz,  2H); 13C NMR (126 MHz, CDCl3) δ 194.2, 152.4, 
135.2, 127.4, 118.9, 117.5, 116.1, 42.0, 38.0.  
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3.2.5  1-(2,2,2-Trifluoroacetyl)-2,3-dihydroquinolin-4(1H)-one:13 
 
N
H
O
N
O
O
F
F
F
 
2,3-Dihydroquinolin-4(1H)-one (1.0 g, 6.8 mmol) was dissolved in dichloromethane (30 
mL). Triethylamine (2.1 g, 20.7 mmol) was added and the mixture was stirred for 10 min 
and cooled to 0 °C. Trifluoroacetic anhydride (3.0 g, 14.2 mmol) was added dropwise and 
the mixture was allowed to reach room temperature. The reaction mixture was stirred for 4 
h at room temperature and water (50 mL) was added. The organic phase was removed and 
the aqueous phase was extracted with dichloromethane (100 mL). The combined organic 
phases were dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure 
to give 1-(2,2,2-trifluoroacetyl)-2,3-dihydroquinolin-4(1H)-one as colourless liquid (1.3 g, 
78%). νmax (film)/cm−1: 3076, 1690, 1600, 1480, 1202; 1H NMR (500 MHz, CDCl3) δ 7.89 
(d, J = 9.0 Hz, 1H), 7.68 (s, 1H), 7.52 – 7.45 (m, 1H), 7.24 (t, J = 7.6 Hz, 1H), 4.11 (t, J = 
6.0 Hz, 2H), 2.78 – 2.75 (t, J = 6.0 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 134.4, 127.8, 
127.1, 126.4, 115.1 (q, CF3, J = 288 Hz), 46.5, 45.6, 45.5, 39.2, 14.4, 10.5. 
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3.2.6  1-(2,2,2-Trifluoroacetyl)-1,2-dihydroquinolin-4-yl acetate: 
 
N
O
O
F
F
F
N
O
O
F
F
F
O
 
 
Following the general procedure for the synthesis of acetate enol esters using 1-(2,2,2-
trifluoroacetyl)-2,3-dihydroquinolin-4(1H)-one (2.5 g, 10 mmol), isopropenyl acetate (100 
mL) and p-toluenesulfonic acid monohydrate (0.2 g, 0.1 equiv., 1.1 mmol) to give the desired 
product as yellow oil (1.2 g, 41%). νmax (film) /cm−1; 3000, 1755, 1702, 1600, 1484, 1269, 
1209; 1H NMR (500 MHz, CDCl3) δ 8.05 (dd, J = 7.9, 1.6 Hz, 1H), 7.73 (dd, J = 8.5, 1.9 
Hz, 1H), 7.63 – 7.56 (m, 1H), 7.39 – 7.32 (m, 1H), 5.44 (dd, J = 9.6, 4.4 Hz, 1H), 4.35 (dd, 
J = 13.7, 4.4 Hz, 1H), 4.14 (dd, J = 13.8, 9.6 Hz, 1H), 2.13 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 188.2, 169.3, 141.4, 135.1, 128.5, 127.4, 125.1, 124.1, 117.3, 115.1 (q, CF3, J = 
288 Hz), 70.7, 48.9, 20.4. m/z: [M+H]+ : 286.0685; [C13H10F3NO3+H] requires 286.0686. 
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3.2.7  2,2-Dimethylchroman-4-one:14 
 
OH
O
O
O
 
 
Hydroxyacetophenone (4 g, 29.4 mmol) was dissolved in EtOH (50 mL). Pyrrolidine (4.1 g, 
57.7 mmol) and acetone (17 mL) were added sequentially and the reaction mixture was 
heated under reflux for 12 h. After the completion of the reaction was observed by TLC, the 
reaction mixture was concentrated in vacuo. The residue was re-dissolved in 
dichloromethane and washed several times with 1M HCl solution. After washing with brine, 
the combined organic layer was dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure. The residue was purified by silica gel using n-pentane/ethylactate 
(6:1) to afford the desired product as colorless crystal (4.5 g, 86%). νmax (film)/cm−1: 3000, 
1768, 1208; 1H NMR (500 MHz, CDCl3) δ 7.89 (dd, J = 7.8, 1.7 Hz, 1H), 7.52 – 7.47 (m, 
1H), 7.00 (td, J = 7.6, 1.0 Hz, 1H), 6.95 (dd, J = 8.4, 0.6 Hz, 1H), 2.75 (s, 2H), 1.49 (s, 6H); 
13C NMR (126 MHz, CDCl3) δ 192.5, 159.9, 136.1, 126.5, 120.6, 120.2, 118.3, 79.1, 48.9, 
26.6. 
 
 
 
 
 
 
 
 
Chapter 3 – Experimental 
 
 
103 
 
3.2.8  (3,4-Dihydronaphthalen-1-yl)oxy)triisopropylsilane:15 
 
 
O O
Si
 
 
The ketone (1.45 g, 5 mmol) and triethylamine (2.09 ml, 9.0 mmol) were dissolved in 
dichloromethane (15 ml). Triisopropylsilyl triflate (4 ml, 6.0 mmol) was added and the 
reaction mixture stirred overnight. The ether solution was concentrated under reduced 
pressure and the residue purified using basic alumina column chromatography using hexane 
as the eluent to give the desired compound as yellow oil (1.20 g, 40%). νmax (film) /cm−1: 
2943, 2860, 1640, 1256,; 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 6.3 Hz, 1H), 7.25 – 7.11 
(m, 3H), 5.19 (t, J = 4.7 Hz, 1H), 2.82 – 2.73 (t, J = 8.2 Hz, 2H), 2.37 – 2.27 (m, 2H), 1.36 
– 1.26 (m, 3H), 1.16 (d, J = 7.2 Hz, 18H); 13C NMR (101 MHz, CDCl3) δ 148.4, 137.1, 
133.7, 127.1, 126.8, 126.1, 121.9, 103.8, 28.2, 22.2, 18.1, 12.8. 
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3.2.9   3,4-Dihydronaphthalen-1-yl diethylphosphinate:16 
 
 
O O
P
O
O
O
 
 
Diisopropylamine (2.94 ml, 21 mmol) was dissolved in anhydrous THF (50 ml) and the 
solution was cooled to –78 °C. n-BuLi (8.4 ml, 21 mmol, 2.5 M in hexane) was slowly added. 
α-Tetralone (2.68 g, 20 mmol) was dissolved in anhydrous THF (10 ml) at –78 °C and the 
LDA solution was added. The mixture was stirred under an argon atmosphere for 1 h at –78 
°C. Diethylphosphorochloridate (5.1 g, 30 mmol) was dissolved in anhydrous THF (5 ml) 
and the solution was added dropwise to the reaction mixture. The mixture was allowed to 
reach room temperature and stirred for 1 h at ambient temperature. The solvents were 
removed under reduce pressure, the residue was dissolved in diethyl ether (100 mL), and 
washed with saturated NH4Cl (50 mL), and water (50 mL). The organic layer was dried over 
anhydrous MgSO4, filtered and the solvents removed under reduced pressure. The residue 
was purified using silica gel column chromatography using petroleum ether-EtOAc (5:1 v/v) 
as the eluent to give the desired enol phosphate as a yellow oil (2.93 g, 69%). νmax (film) 
/cm−1: 3000, 1240, 1600; 1H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 6.2 Hz, 1H), 7.25 – 7.13 
(m, 3H), 5.91 (t, J = 4.7 Hz, 1H), 4.28 – 4.19 (m, 4H), 2.83 (t, J = 8.1 Hz, 2H), 2.47 – 2.40 
(m, 2H), 1.38 (t, J = 7.1 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 145.4, 137.0, 131.2, 128.3, 
127.6, 126.8, 121.9, 111.5, 67.0, 65.9, 26.2, 22.1, 16.8.  
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3.2.10  3,4-Dihydronaphthalen-1-yl benzoate:17 
O
O
O
 
 
1-Tetralone (2.5 g, 17 mmol) and benzoic anhydride (3.8 g, 16 mmol) were dissolved in 
hexane (100 mL) and perchloric acid (0.2 mL) was added. The reaction mixture was stirred 
at room temperature for 2 h. The mixture was filtered to remove the solids formed. The 
filtrate was washed with NaOH (1N, 100 mL), saturated NaHCO3 (100 mL), and brine (100 
mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The 
residue was purified using silica gel column chromatography using n-pentane/ethylactate 
(6:2) to afford 1-benzoyloxy-1-cyclohexene as a colourless liquid (1.09 g, 26%). νmax (film) 
/cm−1: 3000, 2841, 1736, 1500; 1H NMR (500 MHz, CDCl3) δ 8.25 (dd, J = 8.2, 1.1 Hz, 2H), 
7.71 – 7.65 (m, 1H), 7.56 (t, J = 7.7 Hz, 2H), 7.24 – 7.15 (m, 4H), 5.88 (t, J = 4.7 Hz, 1H), 
2.97 (t, J = 8.1 Hz, 2H), 2.59 – 2.52 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 165.0, 145.8, 
136.4, 133.5, 130.5, 130.1, 129.5, 128.6, 128.0, 127.6, 126.4, 120.8, 115.7, 27.5, 22.1.  
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3.2.11   Tert-Butyl-((3, 4-dihydronaphthalen-1-yl)oxy)diphenylsilane:18 
 
O SiO
 
 
 
Potassium hexamethyldisilazide (0.7 g, 3.5 mmol) was dissolved in tetrahydrofuran (12 mL) 
and the solution as cooled to –78 °C.  Α-Tetralone (0.3 g, 2.0 mmol) was added dropwise by 
syringe. The resulting pale-brown solution was stirred for 20 min at –78 °C. tert-
butylchlorodiphenylsilane (0.75 mL, 2.7 mmol) was added dropwise by syringe, and the 
reaction mixture was stirred for 5 min at –78 °C. The reaction mixture was allowed to reach 
room temperature and was stirred for 1 h. The solvents were removed under reduced 
pressure. The pale-yellow oily residue was dissolved in pentane (20 mL), the solution was 
filtered through a pad of Celite and the filtrate was concentrated under reduced pressure. The 
residue was purified using silica gel column chromatography (hexanes) to provide tert-
butyl(3,4-dihydronaphthalen-1-yloxy)diphenylsilane as a colourless solid (0.35 g, 45%).  mp 
= 64-69 °C [Lit.18 mp 69 °C];  νmax (film) /cm−1: 2937, 2700, 1638, 1250, 1113; 1H NMR 
(500 MHz, CDCl3) δ 7.72 – 7.69 (m, 4H), 7.35 – 7.02 (m, 10H), 4.69 (t, J = 4.7 Hz, 1H), 
2.58 (t, J = 7.9 Hz, 2H), 2.09 – 1.89 (m, 2H), 1.04 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 
145.6, 135.1, 133.3, 131.3, 130.7, 127.6, 125.5, 125.2, 124.9, 124.2, 119.7, 103.6, 25.9, 24.5, 
19.9, 17.4.  
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3.2.12  1-(Diethoxyphosphoryl)ethyl acetate:19 
 
 
 
 
1-Bromoethyl acetate (0.66 mL, 5.9 mmol) was treated with triethylphosphite (1.30 mL) at 
room temperature and the resulting dark red mixture was heated to 100 °C. After 2 h, the 
mixture was allowed to reach room temperature and was directly loaded onto a short pad of 
silica gel (10 cm). The filtrate was concentrated by rotary evaporation yielding 1-
(diethoxyphosphoryl)ethyl acetate as a yellow oil (0.6 g, 45%). νmax (film) /cm−1: 2986, 1751, 
1228. 1H NMR (500 MHz, CDCl3) δ 5.23 (m, 1H), 4.10 (m, 4H), 2.05 (s, 3H), 1.40 (d, J = 
7.8 Hz, 3H), 1.27 (t, J = 6.9 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 169.7, 62.9, 29.6, 20.9, 
16.4, 15.1. 31P NMR (202 MHz, CDCl3) δ 21.50.  
 
 
 
 
 
 
 
 
 
 
 
P
O
O
O
O
O
O
O
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3.2.13    1,2,4-Trimethoxy-5-(2-methoxyvinyl)benzene:19 
 
O
O
O
O O
O
O
O
 
 
Methoxymethyl triphenylphosphonium chloride (4.39 g 12.8 mmol) was dissolved in 
anhydrous tetrahydrofuran (34 mL) and n-butyllithium (5.14 mL, 2.5 M in hexane, 19.2 
mmol) was added at 0 °C. After 30 min, 2,4,5-trimethoxybenzaldehyde (2.00 g, 10.2 mmol) 
was dissolved in anhydrous tetrahydrofuran (10 mL) and the resulting solution was added to 
the reaction mixture. The mixture was stirred for a further 30 min. Water (30 mL) was added 
and the aqueous phase was extracted with dichloromethane. The combined organic phases 
were dried over MgSO4 and the solvent was removed under reduced pressure. The residue 
was purified by flash column chromatography on silica gel using n-pentane/diethyl ether 
(5:1) to afford 1,2,4-trimethoxy-5-(2-methoxyvinyl)benzene (1.5 g, 65%). νmax (film) /cm−1: 
2996, 1642, 1507, 1214. 1H NMR (500 MHz, CDCl3) δ 7.69 (s, 1H), 7.07 (d, J = 13.0 Hz, 
1H), 6.82 (s, 1H), 6.55 (s, 1H), 6.53 (s, 1H), 6.13 (d, J = 7.2 Hz, 1H), 6.00 (d, J = 13.0 Hz, 
1H), 5.60 (d, J = 7.2 Hz, 1H), 3.91 (s, 6H), 3.89 (s, 3H), 3.88 (s, 3H), 3.86 (s, 3H), 3.84 (s, 
3H), 3.79 (s, 3H), 3.72 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 150.4, 150.2, 148.4, 147.8, 
147.7, 146.4, 143.3, 142.8, 117.1, 116.9, 113.5, 110.0, 100.2, 98.7, 98.3, 97.6, 60.5, 56.8, 
56.6, 56.5, 56.4, 56.3, 56.2, 56.0. m/z: [M+H]+ : 225.1122; [C12H6O4+H] requires 225.1121. 
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3.2.14  2-(2,4,5-Trimethoxyphenyl)acetaldehyde:20 
 
O
O
O
O
O
O
O
O
 
 
1,2,4-Trimethoxy-5-(2-methoxyvinyl)benzene (0.25 g, 1.1 mmol) was dissolved in 
tetrahydrofuran (20 mL) and an aqueous HCl solution (3M, 1.8 mL) was added. The mixture 
was heated under reflux for 5 h, and quenched with saturated aqueous Na2CO3. The aqueous 
layer was extracted with EtOAc, and the organic layer was washed with brine, dried over 
MgSO4, and concentrated under reduced pressure. The residue was purified by a silica gel 
column chromatography using EtOAc/hexanes (2:3) to obtain 2-(2,4,5-
trimethoxyphenyl)acetaldehyde as a colourless oil (0.18 g, 77%). νmax (film) /cm−1: 2936, 
1721, 1516, 1206. 1H NMR (500 MHz, CDCl3) δ 9.59 (t, J = 2.2 Hz, 1H), 6.61 (s, 1H), 6.49 
(s, 1H), 3.83 (s, 3H), 3.76 (s, 3H), 3.73 (s, 3H), 3.52 (d, J = 2.2 Hz, 2H). 13C NMR (126 
MHz, CDCl3) δ 200.3, 151.9, 149.4, 149.2, 143.1, 115.0, 112.0, 97.5, 56.6, 56.2, 44.9. m/z: 
[M+H]+ : 211.0965; [C11H14O4+H] requires 211.0965. 
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3.2.15  1-(2,4,5-Trimethoxyphenyl)propan-2-ol:21 
 
O
O
O
O
O
O
O
OH
 
 
2-(2,4,5-Trimethoxyphenyl)acetaldehyde (0.23 g, 1.0 mmol) was dissolved in anhydrous 
tetrahydrofuran (5 mL) at 0 °C and MeLi (1.5 mL, 1.60 M in Et2O, 2.4 mmol) was added 
over 1 hour. The resulting mixture was stirred at 0 °C for 30 min and for a further 3h at rt. 
After this time, the mixture was poured into a saturated solution of NH4Cl (25 mL) and the 
layers separated. The aqueous phase was extracted with Et2O and the combined organic 
phases were washed successively with H2O (25 mL) and brine (25 mL), dried (Na2SO4) and 
concentrated under reduced pressure. The residue was purified using silica gel column 
chromatography using EtOAc/hexanes (4:6) to yield of 1-(2,4,5-trimethoxyphenyl)propan-
2-ol as a colourless oil (0.08 g, 35%). νmax (film) /cm−1: 3401, 2932, 1513, 1204. 1H NMR 
(500 MHz, CDCl3) δ 6.74 (s, 1H), 6.57 (s, 1H), 4.09 – 4.03 (m, 1H), 3.92 (s, 3H), 3.87 (s, 
3H), 3.85 (s, 3H), 2.82 (dd, J = 13.6, 4.1 Hz, 1H), 2.68 (dd, J = 13.6, 8.0 Hz, 1H), 1.26 (d, J 
= 6.2 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 151.7, 148.3, 143.0, 118.3, 115.3, 97.8, 68.3, 
56.6, 56.3, 56.2, 39.9, 22.9. m/z: [M+H]+ : 227.1276; [C12H18O4+H] requires 227.1278. 
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  3.2.2 Oxidation section:  
 
3.2.18  General Procedure for enol oxidation: 
 
R
O
R
R
R
O
R
O
R
 
3.2.16.1 Using mCpBA:  
NaHCO3 (2 equiv.) was suspended in dichloromethane (2 mL per 100 mg of enol) and the 
mixture was cooled to 0 °C. Meta-chloroperoxybenzoic acid (1.5 equiv.) was then added. 
The mixture was stirred for 10 min. The enol ether (0.2 g) was added. The reaction was then 
followed by TLC till complete consumption of the starting material. Diethyl ether was then 
added (10 mL) and the reaction mixture was washed with water (10 mL), aqueous Na2CO3 
(3 x 10 mL) and brine (10 mL). The organic phase was then dried on anhydrous Na2SO4 and 
evaporated under reduced pressure. The residue was purified using column chromatography 
on silica gel (eluent: hexanes/ethyl acetate 95:5) to give the desired compound.  
 
3.2.16.2  Using TPPP: 
The catalyst (0.1 equiv.) and the enol ether were dissolved in 
chloroform/acetonitrile/dichloromethane (2 mL per 100 mg of enol) and the mixture was 
cooled. TPPP (2 equiv.) was then added to the mixture. The reaction was followed by TLC 
till complete consumption of the starting material. Diethyl ether was then added (10 mL) and 
the reaction mixture was filtered on a pad of celite. The mixture was then concentrated under 
reduced pressure and the residue was purified using column chromatography on silica gel 
(eluent: hexanes/ethyl acetate 95:5) to give the desired compound. 
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3.2.16.3  2-((Triisopropylsilyl)oxy)-3,4-dihydronaphthalen-1(2H)-one:22 
 
OO
Si
O
Si
 
 
Prepared according to the general procedure for enol oxidation using ((3,4-
dihydronaphthalen-1-yl)oxy)triisopropylsilane (0.20 g, 0.73 mmol), meta-
chloroperoxybenzoic acid (0.17 g, 0.9 mmol) and sodium bicarbonate (0.10 g, 1.11 mmol) 
to give 2-((triisopropylsilyl)oxy)-3,4-dihydronaphthalen-1(2H)-one (0.19 g, 89%). νmax 
(film) /cm−1: 2941, 2865, 1700, 1903, 1295. 1H NMR: δH (500 MHz; CDCl3): 1.1 (d, J = 
6.7 Hz, 18H); 1.25 ( 3H, m), 3 (2H, m); 3.15 (t, J = 7.1 Hz, 2H); 4.5 (dd, J = 7.1 Hz, 1H) 7.2 
(3H, m); 8 (d, J = 7.0 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 197.2, 143.5, 133.3, 132.0, 
128.6, 127.7, 126.5, 74.7, 32.9, 27.1, 17.9, 12.2. 
 
3.2.16.4 2,2-Dimethyl-3-((triisopropylsilyl)oxy)chroman-4-one:22 
O O
OO
Si
O Si
 
 
Prepared according to the general procedure for enol oxidation using (2,2-dimethyl-2H-
chromen-4-yl)oxy)triisopropylsilane (0.20 g, 0.6 mmol), meta-chloroperoxybenzoic acid 
(0.15 g, 0.9 mmol) and sodium bicarbonate (0.10 g, 1.1 mmol) to give 2,2-dimethyl-3-
((triisopropylsilyl)oxy)chroman-4-one (0.13 g, 62 %). 1H NMR: δH (400 MHz; CDCl3): 1.1 
(d, J = 6.8 Hz, 18H); 1.25 ( 3H, m), 1.44 (6H, s); 4.49 (1H, s); 6.5-7.5 (4H, m).  
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3.2.16.5  1-Oxo-2,3-dihydro-1H-inden-2-yl acetate:23 
 
O
O
O
O
O
 
 
Prepared according to the general procedure for enol oxidation using 1H-inden-3-yl acetate 
(0.50 g, 2.8 mmol), meta-chloroperoxybenzoic acid (1.40 g, 8.13 mmol) and sodium 
bicarbonate (0.40 g, 4.7 mmol) to give the desired product (0.25 g, 46%). νmax (film) /cm−1: 
2932, 1745, 1726. 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 7.7 Hz, 1H), 7.67 (td, J = 7.6, 
1.1 Hz, 1H), 7.50 – 7.41 (m, 2H), 5.45 (dd, J = 8.0, 4.9 Hz, 1H), 3.68 (dd, J = 16.9, 8.0 Hz, 
1H), 3.07 (dd, J = 16.9, 4.8 Hz, 1H), 2.21 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 200.6, 
170.4, 150.4, 135.9, 134.5, 128.1, 126.6, 124.5, 74.0, 33.4, 20.8.  
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3.2.16.6   1-Oxo-1-phenylpropan-2-yl acetate:24 
 
O O
OO
O
 
 
Prepared according to the general procedure for enol oxidation using 1-phenylprop-1-en-1-
yl acetate (0.2 g, 1.1 mmol), meta-chloroperoxybenzoic acid (0.3 g, 1.7 mmol) and sodium 
bicarbonate (0.2 g, 2.3 mmol) to give the desired product (0.1 g, 40%). νmax (film) /cm−1: 
3004, 1764, 1206. 1H NMR (500 MHz, CDCl3) δ 7.35 – 7.22 (m, 5H), 3.12 (q, J = 5.3 Hz, 
1H), 2.07 (s, 3H), 1.40 (d, J = 5.3 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 169.1, 136.1, 
128.8, 128.5, 125.5, 84.9, 61.3, 21.0, 13.8.  
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3.2.16.7  5-Oxo-6,7,8,9-tetrahydro-5H-benzo[7]annulen-6-yl acetate:25 
 
O O
O
O
O
 
 
Prepared according to the general procedure for enol oxidation using 6,7-dihydro-5H-
benzo[7]annulen-9-yl acetate (1 g, 5 mmol), meta-chloroperoxybenzoic acid (1.2 g, 7.4 
mmol) and sodium bicarbonate (0.8 g, 9.5 mmol) to give the desired product (0.6 g, 56%).  
1H NMR (500 MHz, CDCl3) δ 7.72 – 7.68 (m, 1H), 7.19 (dd, J = 5.7, 3.4 Hz, 2H), 7.02 (dd, 
J = 5.4, 3.6 Hz, 1H), 3.52 (t, J = 4.7 Hz, 1H), 3.20 – 3.09 (m, 1H), 2.68 – 2.59 (m, 1H), 2.20 
– 2.12 (m, 1H), 1.97 (s, 3H), 1.93 – 1.83 (m, 1H), 1.61 – 1.42 (m, 2H). 
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3.2.16.8  2-Hydroxy-3,4-dihydronaphthalen-1(2H)-one: 
 
R=
 
1-
 acetate
 enol
 ester.      
2-
 
benzoic
 enol
 ester.      
3-
 
phosphinate
 enol
 ester.      
4-
 
trifluoroacetate
 enol
 ester.      
5-
 
tert-Butyl
 
diphenylsilane
 enol
 ether.
OR O
OH
 
 
Prepared according to the general procedure for TPPP enol epoxidation, catalyst (0.1 equiv) 
and the enol ether (1 equiv). νmax (film) /cm−1: 3475, 3066, 1686, 1603. 1H NMR (400 MHz, 
CDCl3) δ 8.07 (dd, J = 7.8, 1.2 Hz, 1H), 7.55 (td, J = 7.5, 1.4 Hz, 1H), 7.37 (t, J = 7.6 Hz, 
1H), 7.30 (d, J = 7.8 Hz, 1H), 4.41 (dd, J = 13.5, 5.4 Hz, 1H), 3.24 – 3.00 (m, 2H), 2.62 – 
2.50 (m, 1H), 2.15 – 1.98 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 200, 145, 135, 130, 129, 
128, 127, 74, 32, 27.  
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General Procedure for protecting group removal: 
 
 
R
O
R
O
R
R
O
R
OH
 
 
The compound was dissolved in methanol (5 mL per 100 mg of starting material) and 
camphorsulphonic acid (1.1 equiv) was added. The reaction was followed by TLC till 
complete consumption of the starting material. The mixture was then concentrated under 
reduced pressure and the residue was purified using column chromatography on silica gel 
(eluent: hexanes/ethyl acetate 3:1) to give the corresponding α-hydroxy-carbonyl. 
 
3.2.17.1  2-Hydroxy-2,3-dihydro-1H-inden-1-one:26 
 
O
O
O
O
OH
 
 
Prepared according to the general procedure for protecting group removal using 1-oxo-2,3-
dihydro-1H-inden-2-yl acetate (0.15 g, 0.8 mmol) and camphorsulphonic acid (0.20 g, 0.9 
mmol) to give 2-hydroxy-2,3-dihydro-1H-inden-1-one (0.1 g, 86%). νmax (film) /cm−1: 3414, 
2923, 1718, 1609. 1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 7.7 Hz, 1H), 7.67 (td, J = 7.5, 
1.2 Hz, 1H), 7.53 – 7.41 (m, 2H), 4.58 (dd, J = 7.9, 5.1 Hz, 1H), 3.62 (dd, J = 16.5, 7.9 Hz, 
1H), 3.05 (dd, J = 16.5, 5.1 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 206.45, 150.9, 135.9, 
134.0, 128.0, 126.8, 124.4, 74.3, 35.1.  
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3.2.17.2   2-Hydroxy-1-phenylpropan-1-one:27 
 
O O
O
OH
O
 
 
Prepared according to the general procedure for protecting group removal using 1-oxo-1-
phenylpropan-2-yl acetate (0.10 g, 0.5 mmol) and camphorsulphonic acid (0.10 g, 0.5 mmol) 
to give 2-hydroxy-1-phenylpropan-1-one (0.07 g, 89%). νmax (film) /cm−1: 3459, 2979, 1682. 
1H NMR (500 MHz, CDCl3) δ 7.86 (dd, J = 8.3, 1.1 Hz, 2H), 7.58 – 7.53 (m, 1H), 7.44 (t, J 
= 7.8 Hz, 2H), 5.15 – 5.04 (m, 1H), 1.38 (d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3) 
δ 202.4, 134.0, 133.3, 128.8, 128.6, 69.3, 22.3.  
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3.2.17.3   6-Hydroxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one:28 
 
O OHO O
O
 
 
Prepared according to the general procedure for protecting group removal using 5-oxo-
6,7,8,9-tetrahydro-5H-benzo[7]annulen-6-yl acetate (0.10 g, 0.5 mmol) and 
camphorsulphonic acid (0.10 g, 0.5 mmol) to give the desired product (0.06 g, 75 %). νmax 
(film) /cm−1: 3420, 3055,2998,1635. 1H NMR (500 MHz, CDCl3) δ 7.66 (dd, J = 7.7, 1.3 
Hz, 1H), 7.34 (td, J = 7.5, 1.5 Hz, 1H), 7.26 – 7.21 (m, 1H), 7.14 (d, J = 7.6 Hz, 1H), 5.36 
(dd, J = 10.7, 5.9 Hz, 1H), 3.02 – 2.86 (m, 2H), 2.21 – 2.11 (m, 2H), 2.00 – 1.89 (m, 1H), 
1.82 – 1.70 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 199.6, 170.2, 141.6, 132.0, 130.0, 129.1, 
126.8, 34.1, 29.2, 23.5, 20.7.  
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3.2.17.4  3-Hydroxy-2,2-dimethylchroman-4-one:30 
 
O
OH
O
O
O O
O
 
 
Prepared according to the general procedure for protecting group removal using 2,2-
dimethyl-4-oxochroman-3-yl acetate (0.10 g, 0.4 mmol) and camphorsulphonic acid (0.10 
g, 0.4 mmol) to give 3-hydroxy-2,2-dimethylchroman-4-one (0.04 g, 49%). νmax (film) 
/cm−1: 3468, 2932, 1766, 1257. 1H NMR (500 MHz, CDCl3) δ 7.26 – 7.19 (m, 3H), 7.16 – 
7.13 (m, 1H), 4.28 (s, 1H), 1.51 (s, 3H), 1.47 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 171.8, 
144.0, 126.8, 125.8, 125.7, 124.7, 119.9, 87.7, 73.3, 23.8, 21.6.  
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3.2.17.5  3-Hydroxy-1-(2,2,2-trifluoroacetyl)-2,3-dihydroquinolin-4(1H)-one: 
 
N
O
O
F
F
F
O O
N
O
O
F
F
F
OH
 
 
Prepared according to the general procedure for protecting group removal using 4-oxo-1-
(2,2,2-trifluoroacetyl)-1,2,3,4-tetrahydroquinolin-3-yl acetate (0.15 g, 0.5 mmol) and 
camphorsulphonic acid (0.1 g, 0.5 mmol) to give 3-hydroxy-1-(2,2,2-trifluoroacetyl)-2,3-
dihydroquinolin-4(1H)-one (0.1 g, 78 %). νmax (film) /cm−1: 3394, 3000, 1696, 1257. 1H 
NMR (500 MHz, CDCl3) δ 8.04 (dd, J = 7.8, 1.6  Hz, 1H), 7.85 (d, J = 8.3 Hz, 1H), 7.62 – 
7.56 (m, 1H), 7.33 (td, J = 7.9, 1.0 Hz, 1H), 4.45 (dd, J = 12.4, 5.3 Hz, 1H), 3.73 – 3.63 (m, 
2H). 13C NMR (126 MHz, CDCl3) δ 194.8, 142.3, 136.2, 135.2, 128.2, 127.2, 124.2, 123.6, 
119.0, 115.1 (q, CF3, J = 288 Hz) 71.5.  m/z: [M+H]+ : 260.0535; [C11H8F3NO3+H] requires 
260.0529. 
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3.3 Catalysts section 
3.3.1 Synthesis of dihydroisoquinolinium salt catalyst 
 
3.3.1.1   2-(2-Bromoethyl) benzaldehyde:31 
O O
Br
 
 
Bromine (4.2 mL, 81.97 mmol) was added to an ice-cooled solution of isochroman (10 g, 
74.52 mmol) in cyclohexane (70 mL) slowly down a reflux condenser over 5 minutes with 
stirring. After the vigorous reaction had calmed, the solution was heated under reflux until 
the reaction turned pale yellow and the liberation of hydrogen bromide gas had ceased. The 
solution was cooled to room temperature, and solvents were removed in vacuo. The 
remaining oil was dissolved in hydrobromic acid (25 mL, 48% aq.) and heated under reflux 
for 10 minutes. The solution was then cooled and extracted with diethyl ether (3 x 100 mL). 
The organic extracts were washed with water (2 x 30 mL), dilute sodium hydrogen carbonate 
(2 x 30 mL), and dried over MgSO4. Removal of the solvents under reduced pressure 
afforded crude 2-(2-bromoethyl) benzaldehyde as an orange-brown oil. Purification by 
vacuum distillation (2 mbar, 50-54 °C) afforded 2-(2-bromoethyl)benzaldehyde as a 
colourless liquid (8.9 g, 57%). νmax (film) /cm−1: 2969, 2743, 1697, 1599, 1291. 1H NMR 
(500 MHz, CDCl3) δ 10.09 (s, 1H), 7.76 (dd, J = 7.6, 1.5 Hz, 1H), 7.49 (td, J = 7.5, 1.6  Hz, 
1H), 7.42 (td, J = 7.5, 1.3 Hz, 1H), 7.27 (dd, J = 7.2, 0.7  Hz, 1H), 3.59 – 3.46 (m, 4H). 13C 
NMR (126 MHz, CDCl3) δ 192.9, 140.5, 134.5, 133.7, 132.1, 127.7, 36.3, 32.7.  
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3.3.1.2  (4S,5S)-N-Formyl-amino-4-(4-methylsulfide)-2,2-dimethyl-1,3-dioxane:32 
 
O
O
N
H
O
S
OH
OH
H2N
S  
 
(S)-Thiomicamine (5.00 g, 23.4 mmol) was dissolved in MeOH (50 mL), and methyl formate 
(1.7 mL, 28.3 mmol) and sodium methoxide (0.1 mL, 2.3 mmol) were added. The mixture 
was stirred for 3.5 h and the solvent removed under reduced pressure to yield N-(1S, 2S)-
1,3-dihydroxy-1-(4-(methylthio)phenyl)propan-2-yl)formamide as a yellow oil. The 
resulting formamide was dissolved in acetone (200 mL), and 2,2-dimethoxypropane (30 mL, 
50.9 mmol) and camphorsulfonic acid (0.5 g, 2.9 mmol) were added. The reaction was stirred 
for 4 h and progress was monitored by TLC. The solvents were removed under reduced 
pressure, and the residue was re-dissolved in ethyl acetate. The solution was washed with 
saturated sodium hydrogen carbonate solution, dried (MgSO4), and the solvents were 
removed under reduced pressure to afford (4S, 5S)-N-formyl-Amino-4-(4-methylsulfide)-
2,2-dimethyl-1,3-dioxane as a colourless oil (5.5 g, 83%). [α]D = + 1.2 ° (c 1.22, CHCl3) 
[Lit.31 [α]D = + 0.9 ° (c 1.00, CHCl3)]; νmax (film) /cm−1: 3296, 2990, 1667, 1496, 1381. 1H 
NMR (500 MHz, CDCl3) δ 8.04 (s, 1H), 7.28 – 7.22 (m, 4H), 6.16 (d, J = 9.1 Hz, 1H), 5.22 
(d, J = 1.9 Hz, 1H), 4.37 – 4.33 (m, 1H), 4.30 (dd, J = 12.1, 1.7 Hz, 1H), 3.93 (dd, J = 12.1, 
1.8 Hz, 1H), 2.50 (s, 3H), 1.62 (s, 3H), 1.59 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 206.9, 
160.4, 126.5, 125.7, 99.7, 71.4, 64.6, 45.3, 30.9, 29.7, 18.5, 15.8.  
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3.3.1.3   (4S,5S)-N-Formyl-amino-4-(4-methylsulfone)-2,2-dimethyl-1,3-
dioxane:32
  
 
O
O
N
H
O
S
O
O
N
H
O
SO
O  
 
(4S,5S)-N-Formyl-amino-4-(4-methylsulfone)-2,2-dimethyl-1,3-dioxane (5.5 g, 19.5 mmol) 
was dissolved in dichloromethane (80 mL) and the solution cooled to 0 °C. m-CpBA (7.4 g, 
43.0 mmol) was dissolved in dichloromethane (100 mL) and dried over MgSO4 before being 
filtered into the cooled solution of the sulfide. The reaction was allowed to warm to ambient 
temperature slowly over 14 h, at which time the reaction was quenched with NaHCO3 (sat. 
aq., 100 mL). The organic layer was separated and washed with 1M NaOH (200 mL) and 
then dried over MgSO4 and carbon black. Solvents were then removed in vacuo to yield the 
product as a white foam of good purity (4.8 g, 78 %). [α]D = - 11.1 ° (c 1.20, CHCl3) [Lit.31 
[α]D = - 14.5 ° (c 1.11, CHCl3)];  νmax (film) /cm−1: 3000, 2874, 1676, 1513, 1382, 1300, 
1202. 1H NMR (500 MHz, CDCl3) δ 8.00 (s, 1H), 7.96 (d, J = 8.5 Hz, 2H), 7.59 (d, J = 8.0 
Hz, 2H), 6.22 (d, J = 9.5 Hz, 1H), 5.31 (s, 1H), 4.47 (dd, J = 12.1, 1.8 Hz, 1H), 4.35 (dd, J 
= 12.1, 1.7 Hz, 1H), 3.92 (dd, J = 12.1, 1.8 Hz, 1H), 3.07 (s, 3H), 1.64 (s, 3H), 1.62 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 160.2, 144.3, 139.8, 127.4, 126.4, 100.0, 71.5, 64.6, 45.0, 
44.5, 29.6, 18.5.  
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3.3.1.4  (4S,5S)- 5-Amino-6-(4-methylsulfone)-2,2-dimethyl-1,3-dioxane:32 
 
 
O
O
N
H
O
O
O
H2N
SO
O
SO
O  
 
(4S,5S)-N-Formyl-amino-4-(4-methylsulfone)-2,2-dimethyl-1,3-dioxane (4.8 g, 15.3 mmol) 
was dissolved in aqueous hydrazine hydrate (100 mL, 85%) and the solution heated under 
reflux for 3 h. The solution was allowed to reach ambient temperature and extracted with 
ethyl acetate (3 x 200 mL). The combined organic layers were washed with water (2 x 200 
mL) and brine (2 x 200 mL), dried (Na2SO4), and the solvents were removed under reduced 
pressure to afford (4S,5S)-5-amino-6-(4-methylsulfone)-2,2-dimethyl-1,3-dioxane as a 
yellow oil (2.2 g, 50%). [α]D= + 48.2 ° (c 1.00, CHCl3) [Lit.31 [α]D = + 65.3 ° (c 1.05, 
CHCl3)];  νmax (film) /cm−1: 3429, 2997, 1642, 1383. 1H NMR (500 MHz, CDCl3) δ 7.99 (d, 
J = 8.4 Hz, 2H), 7.60 (d, J = 8.2 Hz, 2H), 5.25 – 5.13 (d, J = 9.1 Hz, 1H), 4.36 (dd, J = 11.9, 
2.2  Hz, 1H), 3.97 (dd. J = 11.6, 2.3 Hz, 1H), 3.09 (s, 3H), 2.96 – 2.84 (m, 1H), 1.60 (s, 6H). 
13C NMR (126 MHz, CDCl3) δ 146.0, 139.6, 127.5, 126.8, 123.7, 99.6, 49.4, 44.5, 29.6, 
18.6.  
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3.3.1.5    (+)-N-(4S,5S)-2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-yl)-
3,4-dihydroisoquinolinium tetraphenylborate:32 
 
O
O
N
S
O
O
BPh4
O
O
S
O
O
H2N
 
 
A solution of (4S,5S)-2,2-Dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-amine (5.2 
g, 18.2 mmol) in ethanol (30 ml) was added dropwise to an ice-cooled 2-(2 bromoethyl) 
benzaldehyde (3.32 g, 15.4 mmol) solution in ethanol. After the addition was complete the 
reaction flask was lightly stoppered to contain the hydrogen bromide generated temporarily 
in the reaction, and the reaction stirred overnight whilst attaining room temperature. A 
solution of sodium tetraphenylborate (7.4 g, 21.8 mmol) in acetonitrile (4 ml) was added in 
one portion to the reaction and stirred for a further 5 minutes, resulting in the formation of a 
yellow precipitate. The yellow solid was then washed with ethanol (20 ml) and water (20 
ml) and the yellow crystals collected by suction filtration (4 g, 54 %); mp 200-210 °C [Lit.31 
mp 199-200 °C]; [α]D = + 126.5 (c 1.20, Acetone) [Lit.31 [α]D = + 195 ° (c 1.06, Acetone)];  
νmax (film) /cm−1: 1635, 1602, 1571, 1477, 1382, 1313, 1265. 1H NMR (400 MHz, acetone) 
δ 9.38 (s, 1H), 7.95 (d, J = 8.6 Hz, 2H), 7.88 (d, J = 8.6 Hz, 2H), 7.85 – 7.76 (m, 3H), 7.51 
(t, J = 7.6 Hz, 1H), 7.34 – 7.27 (m, 8H), 6.90 (t, J = 7.4 Hz, 8H), 6.75 (t, J = 7.1 Hz, 4H), 
6.12 (d, J = 2.6 Hz, 1H), 4.84 (dd, J = 13.7, 3.1 Hz, 1H), 4.76 – 4.69 (m, 1H), 4.59 (d, J = 
13.6 Hz, 1H), 4.35 – 4.23 (m, 1H), 3.84 – 3.71 (m, 1H), 3.02 (s, 3H), 3.00 – 2.95 (m, 1H), 
2.79 – 2.69 (m, 1H), 1.73 (s, 3H), 1.68 (s, 3H). 13C NMR (100 MHz, acetoned6), δ 168.1, 
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164.4, 142.7, 141.0, 138.7, 137.2, 136.0, 134.6, 128.7, 128.6, 127.8, 126.9, 125.8, 125.7, 
124.6, 121.9, 100.6, 70.4, 56.5, 50.4, 43.9, 29.5, 24.6, 19.04.  
 
3.3.2 Synthesis of biphenyl-derived iminium salt catalyst 
 
3.3.2.1   2,2’-bis(Bromomethyl)biphenyl:34 
Br
Br
OH
OH
 
 
2,2’-Biphenyldimethanol (1 g, 4.6 mmol) was dissolved in neat hydrobromic acid (20 mL) 
at room temperature, and then submitted to reflux for 2.5 h. Reaction progress was monitored 
by TLC, and upon reaction completion, the solution was cooled, toluene (100 mL) added, 
and the organic layer was extracted. The organic extract was washed with saturated sodium 
hydrogen carbonate (100 mL), brine (100 mL), dried (MgSO4), and excess organic solvents 
removed under reduced pressure, affording 2,2’-bis(bromomethyl)biphenyl as a colourless 
solid (0.82 g, 52%; mp 93 °C [Lit.31 mp 92-94 °C]);  νmax (film) /cm−1: 2990, 1736, 1652, 
1598. 1H NMR (500 MHz, CDCl3) δ 7.59 (dd, J = 7.6, 1.3 Hz, 2H), 7.45 (m, 4H), 7.31 (dd, 
J = 7.5, 1.5 Hz, 2H), 4.39 (d, J = 10.1 Hz, 2H), 4.23 (d, J = 10.1 Hz, 2H). 13C NMR (126 
MHz, CDCl3) δ 139.4, 135.8, 130.7, 130.1, 128.6, 128.3, 31.9.  
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3.3.2.2  (4S,5S)-5-Amino-6-phenyl-2,2-dimethyl-1,3-dioxane:35 
 
OH
OH
H2N
O
O
H2N
 
 
 (1S,2S)–(+)–2-Amino-1-phenyl-1,3-propanediol (2.27 g, 9.6 mmol) was dissolved in 
MeOH (50 mL), and methyl formate (1 mL, 16.1 mmol) and sodium methoxide (0.1 mL) 
were added. The mixture was stirred for 3.5 h and the solvent removed under reduced 
pressure. The diol (2.0 g, 10.2 mmol) was then dissolved in acetone (150 mL), and 2,2-
dimethoxypropane (6.4 mL, 50.9 mmol) and camphorsulfonic acid (0.23 g, 1.0 mmol) were 
added. The reaction was stirred for 4 h and progress was monitored by TLC. The solvents 
were removed under reduced pressure, and the residue was re-dissolved in ethyl acetate. The 
solution was washed with saturated sodium hydrogen carbonate solution, dried (MgSO4), 
and the solvents were removed under reduced pressure to afford (4S,5S)-N-Formyl-5-
Amino-4-phenyl-2,2-dimethyl-1,3-dioxane: as a colourless oil (2.3 g, 95 %). (4S,5S)-N-
Formyl-5-amino-4-phenyl-2,2-dimethyl-1,3-dioxane (2.0 g, 8.5 mmol) was dissolved in 
aqueous hydrazine hydrate (100 mL, 85%) and the solution heated under reflux for 3 h. The 
solution was allowed to reach ambient temperature and extracted with ethyl acetate (3 x 200 
mL). The combined organic layers were washed with water (2 x 200 mL) and brine (2 x 200 
mL), dried (Na2SO4), and the solvents were removed under reduced pressure to afford 
(4S,5S)-5-Amino-6-phenyl-2,2-dimethyl-1,3-dioxane as a yellow oil (1.5 g, 86 %). νmax 
(film) /cm−1: 2991, 2940, 2868, 1673, 1586, 1378, 1270, 1239. 1H NMR (500 MHz, CDCl3) 
δ 7.34 – 7.23 (m, 5H), 5.05 (s, 1H), 4.24 (dd, J = 11.8, 2.2 Hz, 1H), 3.87 (dd, J = 11.8, 1.7 
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Hz, 1H), 2.75 (d, J = 1.8 Hz, 1H), 1.49 (s, 3H), 1.48 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 
139.5, 128.2, 127.1, 125.5, 98.8, 73.5, 65.8, 49.4, 29.6, 18.5.  
 
3.3.2.3 (−)-N-[(4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl]-5H 
dibenzo[c,e]azepinium Tetraphenylborate:36 
 
O O
NH2Br
Br
N
O
O
BPh4
 
 
2,2’-bis(Bromomethyl)biphenyl (3.0 g, 8.8 mmol) and amine (1.8 g, 8.8 mmol) were 
dissolved in acetonitrile (30 mL). K2CO3 (2.4 g, 17.4 mmol) was added at room temperature. 
The reaction was submitted to reflux for 24 h, cooled, diluted with CH2Cl2 (100 mL), 
extracted with water (2x 50 mL), brine (2x 50 mL), and dried over MgSO4. Excess solvents 
were removed under reduced pressure, affording 6-(4S,5S)-2,2-dimethyl-4-phenyl-1,3-
dioxan-5-yl)-6,7-dihydro-5H-dibenzo[c,e]azepine (3.2 g, 94 %). 6-(4S,5S)-2,2-Dimethyl-4-
phenyl-1,3-dioxan-5-yl)-6,7-dihydro-5H-dibenzo[c,e]azepine (3.2 g, 8.3 mmol) was then 
dissolved in CH2Cl2 (15 mL), to which N-Bromosuccinimide (1.7 g, 9.9 mmol) was added, 
and left to stir for 5 minutes. Excess dichloromethane was removed under reduced pressure, 
and the remaining solid was re-dissolved in ethanol (30 mL). Sodium tetraphenylborate (3.0 
g, 8.7 mmol) was dissolved in a minimum amount of acetonitrile (4 mL), and added to the 
stirring solution at room temperature. After 5 minutes, the reaction was stopped and excess 
organic solvents removed under reduced pressure, affording (−)-N-[(4S,5S)-2,2-dimethyl-4-
phenyl-1,3-dioxan-5-yl]-5H-dibenzo[c,e]azepinium tetraphenylborate as a pale orange 
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powder (2.2 g, 37 %, mp 170 °C [Lit.31 mp 187 °C]); [α]D = - 42.0 (c 1.01, CH3CN) [Lit.31 
[α]D = - 44° (c 1.01, CH3CN)]; νmax (film) /cm−1: 3054, 3000, 2997, 1631, 1577,1479. 1H 
NMR (400 MHz, DMSO-d6, 115 °C): δ = 1.80 (3H, s), 1.85 (3H, s), 4.41 (1H, d, J = 22 Hz), 
4.51 (1H, d, J = 22 Hz), 4.70–4.73 (1H, m), 4.80 (1H, d, J = 22 Hz), 5.15 (1H, d, J = 22 Hz). 
5.96 (1H, d, J = 4 Hz), 6.75 (4H, t, J = 12 Hz), 6.90 (8H, t, J = 12 Hz), 6.90 -7.11 (5H, m), 
7.28-7.37 (8H, m), 7.42-7.62 (3H, m), 7.74-7.90 (3H, m), 8.06-8.26 (2H, m), 9.09 (1H, s). 
13C NMR (100 MHz, DMSO-d6, 120 °C): δ = 18.2, 28.7 , 54.0, 60.8, 66.1, 70.5, 99.9, 120.7, 
124.46 , 124.47, 124.5, 124.5, 125.3, 127.3, 127.8, 127.9, 128.4, 129.2, 129.5, 129.6, 132.8, 
133.7, 135.0, 136.0, 140.5, 163.3, 170.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.3 Synthesis of binaphthalene-derived iminium salt catalyst 
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3.3.3.1 (R)-[1, 1]-Binaphthalene-2, 2’-diol-bis-trifluoromethanesulfonate:37 
 
  
OH
OH
O
O
S
S
CF3
CF3
O O
O O
 
 
 (R)-Binaphthalenyl-2,2-diol (15.0 g, 52.0 mmol) was dissolved in CH2Cl2 (100 mL) and 
cooled to – 30 °C. After the solution had cooled 4-dimethylaminopyridine (2.5 g, 5.2 mmol), 
2,6-lutidine (18.3 mL, 3 equiv., 157 mmol) and triflic anhydride (44 mL, 3 equiv., 157 mmol) 
were added to the solution. The resulting brown solution was allowed to warm to ambient 
temperature with stirring overnight. Silica gel was added to the dark brown mixture and left 
to stir for 20 mins after which time solvents were removed in vacuo. The loaded silica gel 
was transferred to a sintered glass funnel containing a layer of silica gel under filter paper 
and eluted with hexane until the product had eluted. The solvent was removed under reduced 
pressure to yield (R)-[1,1’]-binaphthalene-2,2’-diol-bis-trifluoromethanesulfonate as a white 
crystalline solid, (26.21 g, 92 %): [α]D = +149.1 (c. 1.01, CHCl3) [Lit.36 [α]D = - 150.9 (c 
1.01, CHCl3)]; νmax (film) /cm−1: 3065, 1509, 1422, 1215, 1139. 1H NMR (500 MHz, CDCl3) 
δ 8.18 (d, J = 9.1 Hz, 2H), 8.05 (d, J = 8.3 Hz, 2H), 7.69 – 7.58 (m, 2H), 7.48 – 7.41 (m, 
4H), 7.29 (d, J = 7.8 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 145.3, 133.1, 132.3, 131.9, 
128.3, 127.9, 127.3, 126.7, 123.2, 119.3, 116.8 (q, CF3, J = 240 Hz).  
 
 
3.3.3.2 (R)-Dimethyl-[1,1’]-binaphthalene:39 
Chapter 3 – Experimental 
 
 
132 
 
 
O
O
S
S
CF3
CF3
O O
O O
 
 
 (R)-[1,1’]-Binaphthalene-2,2’-diol-bis-trifluoromethanesulfonate (26.2 g, 48 mmol) and 
1,3-bis(diphenylphosphino)propane nickel (II) chloride (1.8 g, 3.3 mmol) were dissolved in 
diethyl ether (200 mL) and cooled to – 30 °C. A solution of methylmagnesium bromide (3 
M in Et2O, 64 mL, 192.0 mmol) was added dropwise. After 15 minutes the reaction was 
removed from the Dewar and left to reach ambient temperature with stirring overnight. The 
reaction mixture was diluted with diethyl ether (200 mL) and celite was added to the resultant 
dark brown mixture and stirred for 30 minutes. The suspension was filtered through a 
sintered glass funnel containing celite. The filtrate was washed with 2 M hydrochloric acid 
(40 mL), water (100 mL) and brine (100 mL) and dried (Na2SO4). Removal of the solvent 
under reduced pressure yielded (R)-Dimethyl-[1,1’]-binaphthalene as a white powder, (10.9 
g, 80 %): [α]D = - 40 (c = 1.1 , CHCl3) [Lit.36 [α]D = - 40.9 (c 1.19, CHCl3)]; νmax (film) 
/cm−1: 3051, 2917, 1594, 1506. 1H NMR (500 MHz, CDCl3) δ 7.92 (t, J = 8.1 Hz, 4H), 7.54 
(d, J = 8.4 Hz, 2H), 7.47 – 7.39 (m, 2H), 7.28 – 7.21 (m, 2H), 7.08 (d, J = 8.5 Hz, 2H), 2.07 
(s, 6H). 13C NMR (126 MHz, CDCl3) δ 135.1, 134.3, 132.7, 132.2, 128.7, 127.9, 127.4, 
126.0, 125.6, 124.9, 20.0.  
 
 
 
 
3.3.3.3   (R)-Bis-bromomethyl-[1,1’]-binaphthylenyl:40 
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+ 
Br
Br
 
 
(R)-Dimethyl-[1,1’]-binaphthalene (10.83 g, 38.4 mmol) was dissolved in cyclohexane (85 
mL) with stirring. N-bromosuccinimide (15.0 g, 84.7 mmol) and azobisisobutyronitrile (0.61 
g, 4.3 mmol) were added followed by heating to reflux until disappearance of starting 
material was observed by TLC. After cooling to ambient temperature, water (170 mL) and 
ethyl acetate (28 mL) were added to dissolve by-products and excess NBS. The resulting 
suspension was stirred for 1 h to allow the precipitation of product to complete. The mixture 
was filtered through a Büchner funnel equipped with filter paper and washed through with 
cold cyclohexane, to yield (R)-Bis-bromomethyl-[1,1’]-binaphthylenyl as a white powder, 
(9.6 g, 56 %): [α]D = + 160 (c = 1.0 , CHCl3) [Lit.36 [α]D = + 162.2 (c 1.07, CHCl3)]; νmax 
(film) /cm−1: 3052, 1719, 1508, 1434, 1212.1H NMR (500 MHz, CDCl3) δ 8.06 (d, J = 8.6 
H,+ 2H), 7.96 (d, J = 8.2 Hz, 2H), 7.80 – 7.77 (m, 2H), 7.55 – 7.50 (m, 2H), 7.34 – 7.30 (m, 
2H), 7.11 (d, J = 8.5 Hz, 2H), 4.29 (s, 4H). 13C NMR (126 MHz, CDCl3) δ 134.2, 134.1, 
133.2, 132.5, 129.3, 128.0, 127.7, 126.8, 126.8, 126.8, 32.6.  
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3.3.3.4  (R)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-3H-dinaphtho[2,1- 
c:1',2'-e]azepin-4-ium tetraphenylborate:41 
 
Br
Br O O
NH2
BPh4
N
O
O
 
 
 (4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-amine (0.5 g, 2.4 mmol) was added to solution 
of (R)-Bis-bromomethyl-[1,1’]-binaphthylenyl (1.0 g, 2.4 mmol) and potassium carbonate 
(1.0 g, 7.2 mmol) in acetonitrile (20 mL) at room temperature. The reaction mixture was 
heated under reflux overnight. Solvents were removed under reduced pressure and the 
residue was re-dissolved in dichloromethane (60 mL) and filtered into a separating funnel to 
remove excess K2CO3.The mixture was washed with water (60 mL) and brine (30 mL). The 
organic phase was separated, dried over MgSO4 and solvents removed under reduced 
pressure to give (R)-4-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-4,5-dihydro-3H-
dinaphtho[2,1-c:1',2'-e]azepine (1.1 g, 57%). (R)-4-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-
dioxan-5-yl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (1 g, 2.0 mmol) was then 
dissolve in CH2Cl2 in a flask equipped with a stirrer bar, was added N-Bromosuccinimide 
(0.4 g, 2.2 mmol). The resulting yellow solution was stirred for 1 h after which time the 
solvent removed under reduced pressure. Addition of EtOH the crude mixture was then 
performed. Sodium tetraphenylborate (0.8 g, 2.2 mmol) in the minimum amount of 
acetonitrile was added to this solution. Solvents were again removed under reduced pressure 
to yield an intense yellow foam. EtOH (20 mL) was added and heated until the solid had 
broken up to yield a fine bright yellow precipitate. The solution was allowed to cool to 
ambient temperature and the precipitate filtered off. The precipitate was washed with cold 
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EtOH followed by hexane. Affording (R)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-
yl)-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium tetraphenylborate as a yellow powder (0.8 g, 
49%); m.p. 238 °C [Lit.36 mp 153 °C]); [α]D = - 530 (c = 0.99, acetone) [Lit.36 [α]D = - 357.7 
(c 0.99, acetone)]; νmax (film) /cm−1: 3055, 2998, 1626, 1609, 1588, 1548, 1462, 1383, 1265. 
1H NMR (400 MHz; acetone-D6) δ 9.26 (s, 1H), 8.24 (d, J = 8.6 Hz, 1H), 8.20 (d, J = 8.4 
Hz, 1H), 8.14 (d, J = 8.3 Hz, 1H), 8.05 (d, J = 8.2 Hz, 1H), 7.85 (d, J = 8.6 Hz, 1H), 7.78 (d, 
J = 8.5 Hz, 1H), 7.74 (ddd, J = 8.1, 5.5, 2.5 Hz, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.39 – 7.36 
(m, 2H), 7.28 – 7.23 (m, 8H), 7.23 – 7.19 (m, 1H), 7.12 (d, J = 7.1 Hz, 2H), 7.05 – 7.00 (m, 
4H), 6.98 (t, J = 7.5 Hz, 8H), 6.83 (t, J = 7.2 Hz, 4H), 5.77 (d, J = 2.8 Hz, 1H), 4.76 (d, J = 
13.4 Hz, 1H), 4.62 (dd, J = 14.0, 3.1 Hz, 1H), 4.58 (m, 1H), 4.11 (d, J = 14.0 Hz, 1H), 3.92 
(d, J = 13.5 Hz, 1H), 1.73 (s, 3H), 1.67 (s, 3H).  
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3.4   Tetraphenylphosphonium monoperoxysulfate (TPPP) synthesis procedure:42 
 
PP
Cl HSO5
 
  
Oxone (15 g, 48.8 mmol) was dissolved in deionised water (300 mL) at 10 °C, and 
tetraphenylphosphonium chloride (15 g, 40.0 mmol) dissolved in CH2Cl2 (300 mL) was 
added. The solution was left to stir for ½ hour. Extraction of the organic layer was followed 
by removal of remaining CH2Cl2 under reduced pressure. The white solid was washed with 
distilled water (2 x 75 mL) and then dissolved in CH2Cl2 (200 mL), and dried (MgSO4). To 
the CH2Cl2 solution, hexane (50 mL) was added, and left at –20 °C for 24 hours. The cloudy 
solution was filtered, and any remaining solvents removed under reduced pressure to yield 
white crystalline TPPP (12.506 g, 69%). 1H NMR (400 MHz, CDCl3): δH = 9.24-9.12 (1H, 
S), 7.89 (4H, m), 7.75 (8H, m), 7.59 (8H, m). 
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4.0   APPENDICES 
 
4.1    HPLC trace of racemic epoxidation of 3-Hydroxy-2,2-dimethylchroman-4-one   
 
 
O
O Si
O
O
O Si
O
O
OHiii
 
 
 
Reagents and conditions: (i): m-CPBA (1.5 equiv.), NaHCO3, CH2Cl2; (ii): camphorsulphonic acid (1.1 
equiv), methanol 
 
Data File: C:\EZChrom Elite\Enterprise\Projects\Saud\sm16.dat 
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\1 hour 99.5 0.5 0.5ml.met  
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UV Results     
Retention Time Area Area % Height Height % 
12.650 141498399 49.29 7469548 51.62 
13.767 145566884 50.71 7001718 48.38 
     
Totals     
 287065283 100.00 14471266 100.00 
4.2  Asymmetric epoxidation of 3-Hydroxy-2,2-dimethylchroman-4-one 
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O
O Si
O
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O Si
O
O
OHiii
36%
 ee
 
 
Reagents and conditions: (i): Catalyst 4 (0.1 equiv.), TPPP (2 equiv.), chloroform; (iii): camphorsulphonic 
acid (1.1 equiv), methanol. 
 
Data File: C:\EZChrom Elite\Enterprise\Projects\Saud\sm18.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\1 hour 99.5 0.5 0.5ml.met  
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UV Results     
Retention Time Area Area % Height Height % 
12.623 160818738 68.02 7639827 66.63 
13.717 75610720 31.98 3826612 33.37 
     
Totals     
 236429458 100.00 11466439 100.00 
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4.3   HPLC trace of racemic epoxidation of 2-Hydroxy-3,4-dihydronaphthalen-1(2H)-
one 
 
 
O Si O
O Si
O
OH
i ii
 
 
 
Reagents and conditions: (i): m-CPBA (1.5 equiv.), NaHCO3, CH2Cl2; (ii) camphorsulphonic acid (1.1 
equiv), methanol. 
 
 
Data File: C:\EZChrom Elite\Enterprise\Projects\Saud\sm6.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\1 hour 99.5 0.5 0.5ml.met  
Acquired: 09/03/2012 12:18:22 
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UV Results     
Retention Time Area Area % Height Height % 
29.900 12724692 50.50 280207 51.12 
31.430 12474938 49.50 267907 48.88 
     
Totals     
 25199630 100.00 548114 100.00 
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4.4   Asymmetric epoxidation of 2-Hydroxy-3,4-dihydronaphthalen-1(2H)-one 
 
O
O
O
OHi
98%
 ee
 
 
Reagents and conditions: (i): Catalyst 7 (0.1 equiv.), TPPP (2 equiv.). 
 
Data File: C:\EZChrom Elite\Enterprise\Projects\Saud\sm044a.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\1 hour 99.5 0.5 0.5ml.met  
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UV Results     
     
Retention Time Area Area % Height Height % 
29.757 11362872 98.80 278145 98.54 
31.440 137941 1.20 4131 1.46 
     
Totals     
 11500813 100.00 282276 100.00 
 
Minutes
28.4 28.6 28.8 29.0 29.2 29.4 29.6 29.8 30.0 30.2 30.4 30.6 30.8 31.0 31.2 31.4 31.6 31.8 32.0 32.2
mA
U
-10
0
10
20
30
40
50
60
mA
U
-10
0
10
20
30
40
50
60
29
.8 
 98
.80
1
31
.4 
 1.
19
9
UV
sm044a
sm044a.dat
Retention Time
Area Percent
